Restore balance with personalized bioidentical hormone replacement therapy at ChiroMed. Our integrated approach supports energy, mood, metabolism, sleep, and overall wellness by addressing hormone health as part of a broader functional and patient-centered care plan.

Bioidentical HRT Overview With Integrative Endocrinology

Uncover the role of bioidentical HRT and integrative endocrinology in achieving optimal hormonal balance and vitality.

Abstract

In this post, I walk you through a clear, evidence-based path to understanding hormone optimization and why it is foundational to whole-body health, longevity, and disease prevention. We will explore the physiological roles of key hormones — including estrogen, testosterone, progesterone, thyroid hormones, and vitamin D — and how they influence the brain, heart, bones, metabolism, mood, and pain processing. I will define the difference between treating symptoms and healing root causes, explain the lock-and-key receptor model that distinguishes bioidentical hormones from their synthetic counterparts, and debunk common myths regarding cardiovascular risk and breast cancer. You will see how gut health and the gut-brain axis modulate hormone signaling, why “normal” lab values are not always “optimal,” and how integrative chiropractic care supports the nervous system and the hypothalamic-pituitary-adrenal axis to amplify therapeutic outcomes. Drawing from modern, peer-reviewed findings and my clinical experience, including outcomes documented across my care and education platforms, I present individualized treatment strategies — from transdermal therapy to pellet implantation — and explain exactly when, how, and why each approach is used.

Root-Cause Medicine vs Band-Aid Care: Why Healing Requires Asking “Why”

For decades, I have practiced with a simple guiding principle: “The greatest medicine of all is teaching people how not to need it.” That mindset demands distinguishing treating from healing.

Treating means quieting a symptom while the underlying cause persists. Pain medication for a recurrent headache may silence the alarm without correcting dehydration, nutrient deficiencies, sleep debt, or stress physiology.
Healing requires removing the cause so the body can restore balance — like finding the pebble in the shoe rather than numbing the toe. In hormone care, that pebble is often a deficiency, receptor insensitivity, or axis dysregulation that drives seemingly unrelated symptoms.

When patients arrive on antidepressants, anxiolytics, sleep aids, and stimulants, my position is straightforward: you are not deficient in Prozac or Xanax. Those symptoms are signals of deeper dysregulation. When we correct hormone signaling and support the body’s neuroendocrine and metabolic systems, patients don’t just feel less symptomatic — they recover function, resilience, and clarity. That is healing.

Bioidentical vs Synthetic Hormones: The Lock-and-Key Physiology

Cells communicate through precision. Hormones are keys; receptors are locks. The tighter the molecular fit, the richer the downstream signaling.

Bioidentical hormones have the exact molecular structure your body produces. They fit receptors precisely, triggering entire cascades of gene transcription, enzyme activation, cellular energy production, and repair that extend far beyond stopping a hot flash or improving libido.
Synthetic hormones are structurally altered analogs. They can wedge into the lock and quiet certain symptoms, but they do not reliably initiate the full spectrum of protective responses. Worse, they can “jam” the lock, producing off-target effects and risks seen in large trials of synthetic progestins and oral conjugated estrogens, including clotting and breast cancer risk signals that differ markedly from those associated with transdermal bioidentical estradiol and natural progesterone.

From a healing perspective, injured tissue resolves with nutrients, proper signaling, and innate intelligence — not force. Restoring the body’s native hormonal environment with bioidenticals aligns with physiology and reduces unintended consequences.

The Essential Hormone Suite: What Matters and Why

Hormones are a symphony, not soloists. The following players conduct everything from mitochondrial firing to synaptic plasticity:

Testosterone: In both sexes, testosterone maintains muscle protein synthesis, mitochondrial density, dopamine tone, motivation, and vascular integrity. Clinically, optimizing testosterone often restores energy, drive, and emotional steadiness.
Estrogen: Far beyond reproduction, estrogen modulates lipid profiles, vascular dilation, glucose handling, bone turnover, and neurotransmitter production. It interacts richly with serotonin, GABA, and acetylcholine circuits that govern clarity, memory, and mood stability.
Progesterone: A natural neurosteroid and anxiolytic, progesterone supports sleep architecture via GABAergic pathways, balances the endometrium, reduces mast cell activation, and supports bone formation and neural repair.
Vitamin D (as a secosteroid hormone): Through VDR signaling, vitamin D influences immune tolerance, autoimmunity risk, bone mineralization, muscle performance, and mood regulation. Receptor sensitivity and cellular uptake impact how other hormones exert their effects.
Thyroid hormones (T4/T3): The master metronome of metabolism, thyroid hormones regulate mitochondrial biogenesis, thermogenesis, cholesterol clearance, GI motility, and brain speed. Many patients suffer “normal lab” hypothyroid symptoms due to conversion issues (T4 to T3), inflammation, or stress-axis suppression.

Every intervention we choose respects how these systems interlock.

Finding Hormonal Harmony- Video

When Hormones Drift: The Symptom Constellations I See Every Week

Hormone insufficiency can mimic anxiety disorders, hypothyroidism, chronic fatigue, and fibromyalgia. The pattern recognition is essential:

In women:
- Emotional volatility with swings into irritability or sadness
- Central weight gain, fluid retention, unwanted hair changes
- Brain fog, slowed processing, decreased multitasking capacity
- Sleep fragmentation and poor restorative sleep
In men:
- Loss of drive and diminished initiative
- Sarcopenia: shrinking limbs, growing midsection
- Irritability, anxiety, and flat mood
- Delayed recovery after exercise and joint aches

These are not signs of “aging we must accept.” They are flags of declining signal quality across neuroendocrine axes that can be corrected with targeted care.

Estrogen’s Systemic Power: Brain, Heart, Bone, and Beyond

Declining estradiol produces widespread changes:

Brain and mood: Estrogen modulates serotonin synthesis and receptor sensitivity, supports synaptic density, and reduces neuroinflammation. Because ~80% of serotonin is produced in the gut, estradiol’s influence on mucosal integrity, motility, and microbiome ecology threads directly into mood.
Cardiovascular protection: Estrogen raises HDL, improves endothelial function, and decreases atherogenic inflammatory signaling. Early postmenopausal initiation of estrogen therapy has been associated with profound reductions in cardiovascular events when personalized and appropriately delivered (see references).
Bone remodeling: Estrogen reins in osteoclast activity and preserves trabecular architecture. After menopause, unopposed resorption accelerates — prompting bone loss and joint discomfort that often improves with physiologic replacement.
Urogenital and GI systems: Estrogen maintains urogenital mucosal thickness, reduces susceptibility to UTIs, and supports oral health and the integrity of the colonic epithelium.

In men, a portion of testosterone’s benefits derive from conversion to estradiol via aromatase. Blocking that conversion can backfire — harming bones, vessels, and cognition.

Testosterone: Vital for Both Women and Men

A compelling endocrine fact: across a lifetime, women produce more testosterone than estrogen, yet female testosterone remains underappreciated. In my clinical work and in extensive training settings for medical providers, I find this knowledge gap consistent.

Common deficiency signs in both sexes:
- Afternoon energy collapse (“2 to 4 PM crash”)
- Brain fog and distractibility
- Sarcopenia, increased fat mass
- Low mood, irritability, and anxiety
- Sleep maintenance challenges
- Decreased libido and diminished sense of well-being

The therapeutic aim is not masculinization for women. As Dr. Rebecca Glaser’s research shows, women thrive at levels in the low hundreds (e.g., 100–200 ng/dL), far below male optimization ranges, and nuisance effects (like faster hair growth) are manageable without inducing male traits (Glaser & Dimitrakakis, 2013).

Progesterone: The Great Balancer in Midlife

Progesterone is typically the first hormone to decline in perimenopause, creating estrogen dominance. Natural progesterone:

Balances estrogen by protecting the endometrium and normalizing bleeding patterns
Stabilizes sleep through GABA-A receptor modulation
Calms anxiety by dampening excitatory stress signals
Supports metabolism, helping counter central adiposity
Builds bone by stimulating osteoblast activity
Prevents migraines in hormonally sensitive cycles via neurovascular stability

I use oral bioidentical progesterone strategically at night to align with sleep physiology and reduce cortisol-driven restlessness.

The Gut-Brain Axis: Why Digestion Shapes Hormone Signaling

The gut-brain axis provides a bidirectional highway between microbiome metabolism, mucosal immunity, and central nervous system function. When dysbiosis and leaky gut increase endotoxin exposure, the immune system escalates TNF-alpha and IL-6, which can:

Suppress thyroid conversion (T4 to T3), slowing metabolism
Interfere with steroid receptor sensitivity, blunting hormonal “volume.”
Destabilize serotonin and GABA tone, worsening anxiety and insomnia
Elevate cortisol, skewing glucose handling and fat distribution

Because hormones ride on the integrity of these networks, I routinely assess and address gut ecology — supporting barrier function, microbial balance, and nutrient repletion — to improve hormone outcomes.

Debunking Myths: Sex Hormones, Heart Disease, and Breast Cancer

Fear-mongering around hormones has caused avoidable suffering. Evidence clarifies:

Heart disease reality: Cardiovascular disease causes far more deaths in women than breast cancer, especially after estradiol declines. Early, individualized estrogen therapy is associated with significantly reduced cardiac events when delivered as transdermal bioidentical estradiol and combined with natural progesterone if the uterus is intact (Manson et al., 2013; NAMS, 2017).
WHI interpretation: The increased breast signal in the WHI was tied to synthetic progestin (medroxyprogesterone acetate), not natural progesterone. The Premarin-only arm showed reduced breast cancer incidence in some analyses; clotting risks were linked to oral administration, not transdermal routes. Modern, bioidentical protocols differ materially from those older findings.
Testosterone’s cardiometabolic protection: Hundreds of studies support testosterone’s role in vascular health, insulin sensitivity, lipid balance, and mood. Some benefits reflect physiologic aromatization to estradiol. Routine estrogen blockade with testosterone therapy risks heart, bone, and brain health.

The narrative that “hormones cause breast cancer” is reductive. The real drivers include chronic inflammation, hyperinsulinemia, and toxic exposures. Optimizing hormones within a comprehensive anti-inflammatory and metabolic framework reduces the risk terrain.

Bone and Brain: Hormones as Structural and Cognitive Protectors

Bone health: Estrogen and testosterone have synergistic effects — estrogen restrains resorption; testosterone promotes muscle strength and mechanotransduction, stimulating bone formation. Unlike some antiresorptives that create dense but brittle bone, physiologic hormone restoration improves bone quality, reducing fracture risk when combined with vitamin D, calcium, and resistance training.
Brain health:
- Estrogen exhibits anti-inflammatory and immunomodulatory properties; the brain’s local synthesis of estradiol after injury reflects an innate neuroprotective strategy. Timed delivery of natural estradiol has shown dramatic post-ischemic benefits in experimental contexts.
- Testosterone supports memory, motivation, and synaptic stability; low levels correlate with depression, increased beta-amyloid deposition, cardiometabolic risk, and higher all-cause mortality.
- Pain processing: Both hormones modulate central and peripheral nociceptive pathways. In chronic pain, especially in the context of opioid use, testosterone drops precipitously, compounding pain sensitivity and slowing tissue repair. Optimizing sex hormones often reduces pain perception and accelerates recovery.

Treatment Modalities: How We Choose What to Use and Why

Personalized therapy means aligning the route, dose, and timing to your physiology and preferences.

Oral bioidenticals:
- Progesterone at night synergizes with sleep architecture and GABAergic calming.
- Estradiol can be oral for some, but I prefer transdermal for clot risk mitigation.
- Sublingual testosterone is an option in select cases; we avoid oral synthetic testosterone due to liver and lipid concerns.
Transdermal creams and patches:
- Estradiol patches deliver steady levels and circumvent first-pass hepatic metabolism, reducing clot risk and improving cardiovascular safety profiles.
- Creams can work well; absorption is increased in the genital dermis due to vascularity and a thin epithelium, thereby improving pharmacokinetics.
Injections:
- Effective for testosterone but can cause peaks and troughs, increasing side effects.
- I avoid routine aromatase inhibitors because blocking estradiol harms joint, bone, heart, and brain health.
Pellet therapy (bioidentical):
- Tiny implants placed in subcutaneous gluteal fat deliver steady, cardiac-output-modulated release for months.
- Advantages include consistency, convenience, and individualized dosing without weekly fluctuations.
- In my clinics, we have safely performed tens of thousands of pellet procedures, achieving robust outcomes in energy, mood, body composition, and relationships.

We select a route based on your clot risk, liver status, absorption patterns, lifestyle, and therapeutic goals, and we adjust iteratively with labs and symptom tracking to reach optimal — not merely normal — levels.

Integrative Chiropractic Care: Optimizing the Neuroendocrine Highway

As a DC and FNP, I integrate chiropractic care because the nervous system is the master regulator of the endocrine system. The spine houses the neural pathways that connect the hypothalamus, pituitary, adrenals, thyroid, gonads, and peripheral tissues.

Neurological optimization: Spinal misalignments (subluxations) can impede afferent and efferent signaling, disrupting the feedback loops that maintain hormonal balance. Targeted adjustments restore neural conduction and autonomic tone, improving endocrine responsiveness.
Stress physiology: Adjustments help downregulate sympathetic overdrive and normalize HPA-axis function, lowering chronic cortisol elevations that suppress thyroid conversion, disrupt sex hormone balance, and promote visceral adiposity.
Whole-system synergy: I assess posture, biomechanics, and neural patterns alongside labs and symptoms. When the “power is on,” hormonal signals transmit efficiently — enhancing the impact of bioidentical therapy, gut repair, and nutrient protocols.

This integrative model accelerates outcomes and deepens durability.

Clinical Observations: Real-World Outcomes and Why They Matter

“Gas in the tank” but no ignition: An 18-year-old with high-normal testosterone (~1,000 ng/dL) presented with depression, anxiety, and poor focus. The issue was not production; it was receptor sensitivity. By supporting vitamin D (for VDR and steroid receptor modulation), iodine (for thyroid support), and methylated B vitamins (for methylation and neurotransmitter pathways), his symptoms resolved rapidly. He discontinued psychiatric medications and regained function. This underscores that hormones require cofactors and competent receptors to work.
“Getting her life back at 65”: After synthetic hormones were stopped at age 60 per outdated rules, a patient developed severe depression and withdrawal. Bioidentical pellet therapy restored estradiol, progesterone, and testosterone, and she experienced profound mood and relationship recovery. Her story is emblematic of the shift away from “lowest dose for shortest time” toward individualized, evidence-based longevity care (NAMS, 2017).

My clinical platforms consistently document these transformations across energy, cognition, mood, pain, and relationships, validating the integrated approach.

Why “Normal” Is Not Always “Optimal”

Population-based reference ranges reflect averages — not targets for vitality. Example: a vitamin D level of 35 ng/mL may be “normal,” yet evidence aligns disease prevention and immune optimization with levels typically above 60 ng/mL when individualized and monitored. Similarly, thyroid and testosterone “normalcies” might leave patients foggy, unmotivated, and fatigued.

We test, treat, and retest — using symptom resolution, functional metrics, and lab optimization to find your personalized sweet spot.
The goal is not “not sick.” The goal is vibrant.

Putting It All Together: A Practical, Personalized Pathway

Every plan is individualized, but the strategy follows clear physiology:

Assess and align:
- Detailed history of symptoms, stress, sleep, nutrition, and gut health
- Comprehensive labs: sex hormones, thyroid panel (with free T3), vitamin D, metabolic markers, inflammatory cytokines as indicated
- Chiropractic examination: posture, segmental dysfunction, autonomic balance
Intervene with precision:
- Bioidentical hormones via optimal route (transdermal, pellets, oral progesterone)
- Gut repair: barrier support, microbiome rebalance, anti-inflammatory nutrition
- Nutrient repletion: vitamin D, omega-3s, magnesium, iodine, B-complex (methylated)
- Chiropractic adjustments to normalize neural signaling and HPA-axis tone
- Lifestyle programming: resistance training for bone and insulin sensitivity, sleep optimization for hormone rhythm, stress practices for cortisol control
Monitor and refine:
- Follow-up labs and symptom maps
- Dose adjustments to maintain physiologic ranges and minimize side effects
- Ongoing education so you understand the “why” behind each change

This is how we move from treating to healing.

Key Takeaways For Your Health Journey

Hormone imbalances can occur at any age, affecting mood, energy, muscle function, cognition, and relationships.
Bioidentical hormones fit receptor locks precisely, unlocking protective cascades in brain, heart, bone, and metabolism.
Transdermal estradiol and natural progesterone differ materially from older synthetic regimens, shifting risk profiles and outcomes.
Testosterone is vital for women and men; blocking estrogen in men is typically harmful.
Gut health and the nervous system set the stage for hormone signaling; repair and alignment amplify results.
Normal is not optimal; personalization is essential for long-term vitality.
Integrative chiropractic care enhances neuroendocrine transmission and stress-axis regulation, increasing the efficacy of hormone therapy.

You do not have to live in a fog of fatigue, irritability, and disconnection. With modern, evidence-based, integrative care, you can reclaim clarity, purpose, and a vibrant life.

References

Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials (Manson, J. E., Chlebowski, R. T., Stefanick, M. L., Aragaki, A. K., Rossouw, J. E., Prentice, R. L., … & Wactawski-Wende, J., 2013). JAMA, 310(13), 1353–1368.
The 2017 hormone therapy position statement of The North American Menopause Society (The NAMS 2017 Hormone Therapy Position Statement Advisory Panel, 2017). Menopause, 24(7), 728–753.
Testosterone therapy in women: myths and misconceptions (Glaser, R., & Dimitrakakis, C., 2013). Maturitas, 76(3), 230–234.

SEO Tags: hormone optimization, bioidentical hormones, testosterone therapy for women, estrogen benefits, progesterone sleep support, thyroid optimization, vitamin D hormone, gut-brain axis, integrative chiropractic care, menopause therapy, andropause treatment, pellet hormone therapy, cardiovascular protection, osteoporosis prevention, brain health and hormones, functional medicine, Dr. Alexander Jimenez DC APRN FNP-BC IFMCP, El Paso hormone clinic

May 26, 2026

Cardiometabolic Health Solutions With GLP-1 Therapy

Discover the impact of GLP-1 therapy on cardiometabolic health and how it can benefit individuals seeking better wellness.

Abstract: A New Paradigm in Metabolic Health

Welcome to our educational post on the revolutionary class of medications known as GLP-1 receptor agonists. As a practitioner deeply rooted in integrative and functional medicine, with a diverse background spanning chiropractic (DC), advanced practice nursing (APRN, FNP-BC), and functional medicine (CFMP, IFMCP), my primary goal has always been to find the most effective, evidence-based strategies to improve my patients’ health. My clinical observations at our El Paso and San Antonio clinics, coupled with the latest research, continually point toward a more integrated and holistic approach to chronic disease. This post will serve as your guide, translating complex clinical trials and physiological mechanisms into an easy-to-understand narrative. We will delve into how these powerful agents work, explore the landmark cardiovascular outcomes trials (CVOTs) that revealed their ability to protect the heart and kidneys, and differentiate among the available options, such as semaglutide (Ozempic/Wegovy) and the dual-agonist tirzepatide (Mounjaro/Zepbound). Furthermore, we will delve into the practical aspects of using these therapies, including managing side effects, understanding safety considerations, and exploring their investigational uses in everything from neuroprotection to fertility. Most importantly, we’ll connect these pharmacological advancements back to the core principles of integrative health, examining how integrative chiropractic care is essential for maximizing patient outcomes and achieving true, sustainable well-being.

Rethinking Diabetes: Beyond Glucose-Centric Care

In my years of practice, I’ve seen firsthand the devastating impact of diabetes on my patients’ lives. For decades, the management of type 2 diabetes was primarily focused on lowering blood glucose levels. However, we now understand that this is only one piece of a much larger puzzle. It’s a reality underscored by stark statistics. We know that atherosclerotic cardiovascular disease (ASCVD)—which encompasses coronary heart disease, stroke, and peripheral arterial disease—is the leading cause of death for individuals with type 2 diabetes. In fact, more than 70% of elderly patients with diabetes will likely succumb to heart disease or a stroke. The prognosis following a heart attack is significantly poorer for someone with diabetes compared to someone without, and alarmingly, these outcomes often remain bleak even when blood glucose levels are considered “well-controlled.”
This has forced a critical shift in our clinical strategy. The old model, which I call the “glucose-centric” approach, is no longer sufficient. We must move toward a multifaceted management plan that reduces overall risk. This requires a collaborative and integrative effort.

Pillars of Modern Diabetes Management

The world’s leading medical bodies, including the American College of Cardiology (ACC), the American Heart Association (AHA), the American Diabetes Association (ADA), and the Kidney Disease Improving Global Outcomes (KDIGO) group, are all aligned on this new, comprehensive approach. It’s no longer just about the A1c. Our focus must be on:
Lifestyle Management: Foundational changes in diet and physical activity.
Diabetes Self-Management Education: Empowering patients with the knowledge to control their condition.
Cardiovascular Risk Reduction: Aggressively managing blood pressure, cholesterol (lipids), and, of course, glucose levels.
Weight Management: Addressing excess weight as a key driver of metabolic dysfunction.
Smoking Cessation: Eliminating a major accelerator of cardiovascular disease.
This holistic view is the cornerstone of effective, 21st-century care.

Clinical Case Study: The Challenge of “Over-Basalization”

To illustrate these concepts, let’s consider a case similar to many patients I see in my clinic. We’ll call her Naomi.
Naomi is a 66-year-old female who has been living with type 2 diabetes for 12 years. Despite being on a robust medication regimen, her health is not where it needs to be.
A1c: Her last A1c was 8.3%, well above the target of less than 7%.
Comorbidities: She has high cholesterol (hyperlipidemia), hypertension, and protein in her urine (proteinuria), a sign of early kidney stress.
Medications:
Metformin 1000 mg twice daily.
Degludec insulin (a basal insulin): 66 units daily.
An SGLT-2 inhibitor (a class of oral diabetes medication).
A statin for cholesterol.
An ARB for blood pressure.
Weight: She weighs 220 pounds and is 5’9 “, giving her a BMI of 32.5, placing her in the obese category.
Glucose Readings:
Her fasting glucose levels are between 140 and 160 mg/dL. The goal is typically 90-130 mg/dL.
Her postprandial (after-meal) glucose levels are 160-170 mg/dL. While the ADA goal is under 180 mg/dL, many specialists, including myself, prefer to see this number much lower, ideally under 140 mg/dL two hours after a meal.

The Problem: Over-Basalized and Still Not at Goal

Naomi’s case highlights a common clinical problem: “over-basalization.” She is taking a very high dose of basal insulin, yet her A1c and fasting glucose are still too high. A simple clinical calculation I use is to multiply a patient’s weight in kilograms by 0.5. For Naomi, who weighs 100 kg, this suggests that a basal insulin dose above 50 units may be excessive. At 66 units, she is clearly over-basalized.
The high basal insulin dose isn’t effectively controlling her blood sugar, and it’s likely contributing to her difficulty with weight management. The logical next step in a traditional model might be to add prandial (mealtime) insulin to cover her post-meal glucose spikes. However, this is where we can intervene more intelligently. Before adding more insulin, which often leads to further weight gain and increased risk of hypoglycemia, we should consider a GLP-1 receptor agonist. This approach leverages the body’s natural “incretin effect” to address the very issue Naomi is struggling with: postprandial hyperglycemia.

Understanding GLP-1 Receptor Agonists: The Incretin Effect

To truly appreciate these medications and understand why a GLP-1 agent is such a powerful tool, we need to talk about the “incretin effect.” This term describes a fascinating physiological process that is glucose-dependent, meaning these hormones act primarily when glucose is present. Our bodies naturally produce incretin hormones, specifically GLP-1 (Glucagon-Like Peptide-1) and GIP (glucose-dependent insulinotropic polypeptide), which are synthesized and released by specialized “L-cells” in the jejunum, a part of our small intestine.
This release is triggered by the presence of food in the gut. When you eat a meal, these hormones are secreted into the bloodstream, orchestrating a multi-pronged response:
Stimulates Insulin Secretion: It signals the pancreas to increase insulin secretion, but only in a glucose-dependent manner. This means it only works when blood sugar is high, dramatically reducing the risk of hypoglycemia compared to insulin or other medications.
Suppresses Glucagon Release: It signals the pancreas to stop releasing glucagon, a hormone that prompts the liver to produce more glucose. This prevents unnecessary glucose from entering the bloodstream.
Slows Gastric Emptying: It slows down the rate at which food leaves the stomach. This makes you feel full sooner and for longer, helping to control appetite and prevent sharp, rapid spikes in blood sugar after meals.
Promotes Satiety: It acts directly on the brain to reduce appetite and increase feelings of fullness.
In individuals with type 2 diabetes, this natural incretin effect is often blunted or, in some cases, completely absent. They produce very low levels of their native GLP-1 hormone. This deficiency leads to insufficient insulin secretion after meals and a failure to suppress glucagon. The result is the hallmark hyperglycemia we see in diabetes. GLP-1 receptor agonists are medications designed to mimic the action of our own GLP-1, but they are engineered to last much longer in the body, restoring and amplifying these beneficial effects.

Mechanisms of Action: More Than Just Blood Sugar Control

The mechanisms of these drugs are multifaceted and explain not only their benefits but also their common side effects.
Gastrointestinal System: In the presence of a GLP-1 agonist, gastric emptying is significantly slowed. This delay is a primary reason patients feel full for longer, which naturally leads to reduced food intake and contributes to weight loss. Unfortunately, this slowing effect can also cause side effects like mild nausea and occasionally vomiting, especially in individuals with a history of gastroparesis. Some patients may experience diarrhea, while others report constipation or mild abdominal pain.
Central Nervous System (Brain): We believe that these small-molecule drugs can cross the blood-brain barrier and act directly on the brain’s appetite centers, such as the hypothalamus. This central action helps to decrease appetite and reduce food cravings, providing another powerful mechanism for weight loss. The feeling of prolonged satiety is likely a combination of this central effect and the delayed gastric emptying.
Pancreas: In the pancreas, GLP-1 agonists stimulate glucose-dependent insulin secretion from the beta cells. Simultaneously, they suppress glucagon secretion. By lowering glucagon, they help reduce the liver’s inappropriate production and release of stored glucose, a common dysfunction in type 2 diabetes.

The “Ominous Octet” and the Power of GLP-1s

In 2009, the renowned endocrinologist Dr. Ralph DeFronzo published a seminal paper describing the “Ominous Octet”—eight core pathophysiological defects that contribute to type 2 diabetes (DeFronzo, 2009). This framework helps us understand the complexity of the disease. What is remarkable is that GLP-1 receptor agonists address six of these eight defects very effectively. Their widespread use makes them among the most comprehensive therapies available.

Choosing the Right GLP-1 Agonist: A Comparative Look

The family of GLP-1 agents has grown, offering us a variety of options with distinct profiles. It’s crucial to choose an agent that aligns with the individual patient’s needs. Let’s look at the data from leading researchers to understand the impact of these medications. When we compare these agents, we see a clear progression in efficacy:
Liraglutide resulted in a weight loss of about 2.7 kilograms and a just under 1% reduction in HbA1c.
Dulaglutide improved upon this, showing an average weight loss of 4.6 kilograms.
Semaglutide represented a significant leap forward, demonstrating an average weight loss of 6.4 kilograms and a more robust HbA1c reduction of between 1.8% and 2.1%.
Then came tirzepatide, a dual GIP and GLP-1 receptor agonist, which has shown truly remarkable results. In clinical trials, it was associated with an average weight loss of 11.2 kilograms—almost double that of semaglutide—and an impressive 2.3% reduction in HbA1c.
It’s crucial to note that these powerful results, particularly for weight loss, were observed at the higher doses approved by the FDA during the drug approval process. Here’s a breakdown of the key players, based on the latest research and FDA indications as of May 21, 2026:
Medication (Brand Name)
Key Indications & Benefits
A1c Lowering
Typical Weight Loss
Semaglutide (Ozempic/Rybelsus)
Type 2 Diabetes, Weight Loss (Wegovy), MACE Reduction, Nephropathy Protection. Semaglutide is a potent agent with robust evidence of cardiovascular and kidney benefits.
~1.5-2.0%
~15% of body weight
Tirzepatide (Mounjaro/Zepbound)
Type 2 Diabetes, Weight Loss, OSA. This is a “twincretin,” a dual GLP-1/GIP agonist, showing the highest efficacy for both glucose lowering and weight loss. Cardiovascular outcome trials are ongoing but look promising.
>2.0%
>20% of body weight
Dulaglutide (Trulicity)
Type 2 Diabetes, MACE Reduction, Nephropathy Protection. A reliable weekly injection with proven cardiovascular and kidney benefits, though with more moderate weight loss compared to newer agents.
~1.0-1.5%
~3-5 kg
Liraglutide (Victoza)
Type 2 Diabetes, MACE Reduction, Nephropathy Protection. One of the first GLP-1s with proven cardiovascular benefits, but it requires a daily injection. Weight loss is more modest. A higher dose is available for weight loss (Saxenda).
~1.1%
~2.5 kg
Exenatide (Byetta/Bydureon)
Type 2 Diabetes. One of the earliest GLP-1s. It is effective for glucose control but has less impact on weight and lacks the proven cardiovascular protection of newer agents.
<1.0%
~2.9 kg
MACE = Major Adverse Cardiovascular Events (heart attack, stroke, cardiovascular death). OSA = Obstructive Sleep Apnea.

When I select a GLP-1 agonist for a patient, I’m not just looking at the A1c. For Naomi, who has hypertension and proteinuria, choosing an agent with proven MACE reduction and nephropathy protection like semaglutide (Ozempic) or dulaglutide (Trulicity) would be a critical part of a comprehensive strategy. Given her significant need for weight loss and A1c reduction, semaglutide or tirzepatide would be the top consideration.

Cardiovascular Outcomes Trials (CVOTs): The Game-Changer

The history of diabetes medications is marked by a pivotal moment in 2008. Following safety concerns with earlier drugs, the FDA mandated that all new diabetes drugs undergo large, long-term Cardiovascular Outcomes Trials (CVOTs). The goal was to demonstrate that these new drugs did not harm the cardiovascular system.
What happened next was completely unexpected and revolutionized our field. Not only were these drugs safe, but they also provided robust cardiovascular risk reduction. This discovery shifted the paradigm from “just diabetes drugs” to essential tools for cardiologists and nephrologists. The GLP-1 receptor agonists soon followed with their own impressive CVOT data:
REWIND Trial (Dulaglutide): Showed a 12% reduction in major adverse cardiovascular events (MACE).
LEADER Trial (Liraglutide): Showed a 13% reduction in MACE.
SUSTAIN-6 Trial (Subcutaneous Semaglutide): Showed a remarkable 26% reduction in MACE.
These large, multi-year, double-blind, placebo-controlled studies involving thousands of patients solidified the role of these medications as cornerstones of cardio-renal-metabolic care. We now view metabolic disease through the lens of the cardio-renal-metabolic (CRM) triad. These systems are bidirectionally linked; a problem in one inevitably affects the others.

How Professional Guidelines Position GLP-1 Agonists

The American Diabetes Association (ADA) has recognized the profound benefits of these medications. The 2025 ADA guidelines, published annually in Diabetes Care, place a strong emphasis on GLP-1 receptor agonists, especially for certain patient populations (ElSayed et al., 2024).
The ADA treatment algorithm is divided into two main pathways:
The Left-Hand Pathway: For patients with established atherosclerotic cardiovascular disease (ASCVD), heart failure, or chronic kidney disease (CKD), or those at very high risk. For these patients, a GLP-1 receptor agonist is now strongly favored as a primary agent, sometimes even before metformin.
The Right-Hand Pathway: For patients whose primary needs are glycemic control and weight management but who do not have the high-risk cardiovascular or kidney profile.
For patients with CKD, SGLT2 inhibitors are often the first choice. However, certain GLP-1 agonists, specifically semaglutide, have also earned an indication for kidney protection. The FLOW trial, stopped early due to overwhelmingly positive results, demonstrated that semaglutide reduced the risk of major kidney disease events and cardiovascular death by 24% in people with type 2 diabetes and CKD.

Balancing Body and Metabolism- Video

Navigating the Switch: A Guide to Changing GLP-1 Agonists

As a clinician committed to patient-centered care, I often encounter scenarios in which a medication switch is considered. A recent case involved a patient, we’ll call her Tammy, who was on Trulicity (dulaglutide) but wasn’t achieving her desired weight loss. Through shared decision-making, we explored a switch. This requires a careful, evidence-informed approach.
Switching from Trulicity (dulaglutide) to Ozempic (semaglutide): To switch from a 1.5 mg dose of dulaglutide, I would begin her on semaglutide 0.5 mg weekly. This conservative start minimizes side effects. After a month, if she tolerates it well, we could increase her to a weekly dose of 1 mg.
Switching from Trulicity (dulaglutide) to Mounjaro (tirzepatide): After her last dose of Trulicity, we would wait a full week (a “washout” period) before starting tirzepatide. I would initiate treatment with tirzepatide 5 mg weekly. The goal is to find the optimal dose—the one where the patient achieves significant satiety and weight loss with minimal side effects—by titrating up every four weeks if needed.

The Expanding Universe of GLP-1 Receptor Agonists

The story of GLP-1 agonists is no longer confined to diabetes. The research community is buzzing with discoveries about their far-reaching benefits.

Metabolically Associated Steatotic Liver Disease (MASLD)

One of the most promising frontiers is in liver health. The primary benefit for MASLD and its inflammatory progression, MASH, comes from the significant and sustained weight loss these drugs induce, which directly decreases fat deposition in the liver (Abbasi, 2024). Novo Nordisk is seeking FDA approval for this indication, which we may see by late 2025 or early 2026.

Expanding Indications: Beyond Diabetes

The benefits have proven to extend beyond patients with type 2 diabetes, as established by two landmark trials:
STEP-HFpEF Trial: This study showed that in patients with obesity-related heart failure with preserved ejection fraction (HFpEF), semaglutide led to significant improvements in heart failure symptoms and physical limitations, regardless of whether the patients had diabetes (Kosiborod et al., 2023).
SELECT Trial: This trial involved over 17,000 overweight or obese patients with pre-existing heart disease but without diabetes. The group receiving semaglutide showed a 20% reduction in MACE compared to placebo.

Cravings, Compulsive Behaviors, and Addiction

A consistent report from my own patients is a dramatic reduction in cravings. They describe it as a quieting of the constant “food noise” in their brain, with a decreased desire for alcohol and smoking. This points to a fundamental impact on the brain’s reward pathways.

PCOS, Fertility, and the “Ozempic Babies” Phenomenon

For many women with Polycystic Ovary Syndrome (PCOS), the substantial weight loss from these drugs can restore metabolic balance and regulate menstrual cycles. This has led to enhanced fertility and the recent media phenomenon of “Ozempic babies.”

Other Investigational Uses

Researchers are also observing positive effects in:
Neuroprotection: Patients with dementia and Parkinson’s disease have shown a stall in disease progression, suggesting a neuroprotective effect within the brain.
Latent Autoimmune Diabetes in Adults (LADA): The off-label use of GLP-1 agonists is being studied to help preserve remaining beta-cell function in this form of autoimmune diabetes (Buzzetti et al., 2020).
Respiratory Health: In patients with asthma and COPD, these drugs have been associated with fewer exacerbations, likely due to their anti-inflammatory properties.

The Role of Integrative Chiropractic Care

This is where my perspective as a DC, APRN, and Functional Medicine Practitioner becomes so important. While these medications are incredibly powerful, they are tools, not cures. True, lasting health is achieved when we combine these advanced pharmacotherapies with a foundation of lifestyle and structural wellness.
Optimizing Nervous System Function: The nervous system is the body’s master controller. The gut-brain axis is a two-way communication highway critical for satiety signaling. Chiropractic adjustments can help reduce nerve interference, potentially enhancing the body’s response to these signals and improving the efficiency of the gut-brain connection.
Supporting Musculoskeletal Health During Weight Loss: Rapid and significant weight loss can place new stresses on the body as a patient’s center of gravity shifts. This can lead to new patterns of musculoskeletal pain. Integrative chiropractic care is crucial for managing these biomechanical changes through targeted adjustments, soft-tissue work, and the prescription of corrective exercises.
Addressing the Root Causes: Functional medicine teaches us to ask “Why?” We use a holistic approach to craft personalized nutrition plans, develop sustainable exercise regimens that preserve muscle mass, and implement stress-management techniques to reduce cortisol levels.
Chiropractic care is not an alternative to these medications; it is a vital complement. By ensuring the body’s structure and nervous system function optimally, we create an environment in which these powerful drugs can work most effectively.

Safety, Side Effects, and Practical Recommendations

While transformative, these medications require careful management.

Common GI Side Effects

Nausea: This is the most common side effect, often linked to early satiety.
Constipation or Diarrhea: The effect on motility varies by individual.
Management Strategy: The key is to “start low and go slow.” I start patients on the lowest possible dose for at least a month before considering an increase.

Important Safety Issues

Gallbladder Events: Rapid weight loss can increase the risk of gallstones.
Acute Kidney Injury: Can occur from severe nausea and vomiting leading to dehydration. Staying well-hydrated is critical.
Pancreatitis: Though rare, patients with severe, persistent abdominal pain should seek immediate medical attention.
Surgical Considerations: Anesthesiology guidelines recommend stopping weekly GLP-1 agonists at least one to two weeks before a planned surgery to reduce the risk of aspirating stomach contents.
Muscle and Bone Mass: Significant weight loss involves some loss of lean muscle and bone. I work with patients to incorporate resistance training and ensure adequate protein intake.

Black Box Warning: Thyroid C-Cell Tumors

These medications carry a black box warning regarding the risk of thyroid C-cell tumors observed in rodent studies. While this link has not been established in humans, the drugs are contraindicated in patients with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Final Thoughts: A New Hope for Patients

The advent of modern GLP-1 receptor agonists has fundamentally changed the landscape of diabetes and metabolic care. For patients like Naomi, starting a GLP-1 agonist is not just about adding another medication; it’s about shifting her disease trajectory. It offers the potential to achieve her A1c goal, lose significant weight, reduce her reliance on insulin, and lower her risk of a future heart attack or stroke.
As healthcare providers, it is our responsibility to embrace a comprehensive, integrative approach. By combining the power of these advanced medications with the foundational principles of lifestyle medicine and chiropractic care, we can offer our patients a new level of hope and empower them to achieve a healthier, more vibrant future.

References

SEO Tags: GLP-1 agonists, Semaglutide, Tirzepatide, Ozempic, Mounjaro, Wegovy, Zepbound, Type 2 Diabetes, Weight Loss, Cardiovascular Risk Reduction, Integrative Chiropractic Care, Functional Medicine, Dr. Alexander Jimenez, El Paso Chiropractor, A1c, Postprandial Glucose, Incretin Effect, Metabolic Health, Heart Health, Kidney Disease, CVOT, Ominous Octet, Gastric Emptying, Satiety, MASH, neuroprotection, PCOS, fertility, LADA, patient-centered care, cardio-renal-metabolic health, chiropractic adjustment, musculoskeletal health

May 19, 2026

Hormonal Health Benefits You Need For Patient Wellness

Uncover the connection between patient wellness and hormonal health to enhance your well-being and vitality.

Abstract

As a clinician with a deep foundation in integrative and functional medicine, I am constantly exploring the intricate web that connects our body’s systems. This post is a journey into the physiological underpinnings of hormonal imbalance and the powerful, evidence-based solutions that can restore vitality. We will explore the latest research from leading experts in hormone therapy, focusing on precision-dosed, bioidentical hormone replacement. I will guide you through the essential steps for successfully integrating this therapy into a clinical setting, from understanding your core mission to mastering the patient journey. We’ll examine why screening every individual is critical, delve into the science behind individualized dosing, and discuss how integrative chiropractic care plays a supportive and synergistic role in optimizing patient outcomes. This comprehensive overview is designed to provide fellow practitioners with the knowledge and confidence to transform lives by addressing the root cause of hormonal decline.

Know Your “Why”: The Driving Force Behind Transformative Healthcare

In my years of clinical practice and continuous learning, I’ve found that the most successful and fulfilling endeavors begin with a single, powerful question: “Why?” Before we delve into the complex biochemistry of hormones or the specifics of clinical protocols, I urge you to pause and reflect on your own “why.” Why did you choose this path in healthcare? What change are you hoping to create for your patients?

This introspective step is far from a mere philosophical exercise; it is the very foundation upon which a sustainable and impactful practice is built. Your “why” is the spark that fuels your dedication.

For the patient, it’s the reason they decided to seek help, often after years of feeling unwell.
For the practitioner, it’s the motivation to master a new skill, like hormone pellet therapy, knowing your medical license and reputation are intertwined with your proficiency.

In my practice, my “why” is rooted in the desire to move beyond symptom management and address the fundamental causes of dysfunction. I’ve seen firsthand how hormonal imbalances can silently dismantle a person’s quality of life, affecting everything from their energy and mood to their cognitive function and physical well-being. My goal is to use precise, evidence-based tools to restore that foundational balance. This requires a commitment to repetition and mastery. Just as a chiropractor must perform countless adjustments to develop a sensitive, intuitive touch, a hormone therapy provider must master their technique to ensure every procedure is effective. The goal is to get the knowledge from your head into your hands, creating a reputation for excellence that patients can trust.

So, what is your “why?” Do you want to build a multi-location practice? Sell your practice one day? Or become the most trusted expert in your community? Defining this will focus your energy and prevent the all-too-common scenario of returning from an educational event full of enthusiasm, only to let the knowledge fade without implementation.

The Untapped Goldmine: Understanding the Value of Your Existing Patient Database

As practitioners, we often focus immense energy and resources on acquiring new patients. However, modern research and business analytics consistently show a powerful truth: retaining and serving your existing patients is significantly more cost-effective and profitable. Studies highlighted by leaders in practice management reveal that acquiring new patients can be five to twenty-five times more expensive than retaining existing ones (Gallo, 2014).

Think about the patients already in your practice:

The patient is visiting an OB-GYN for an annual check-up.
The individual sees a primary care provider for a sick visit.
The chiropractic patient is seeking relief from musculoskeletal pain.

These individuals already trust you. They have established a relationship with you and your team. This existing trust is an invaluable asset. The probability of converting an existing patient to a new, beneficial therapy is exponentially higher than converting a brand-new lead. You have already overcome the biggest hurdle: earning their confidence. My clinical observations at our wellness centers confirm this. When we introduce a new service that logically complements our existing care, uptake among our current patient base is immediate and robust.

Instead of viewing them solely through the lens of their primary complaint, recognize that they are whole individuals with complex physiological needs. They are your most valuable resource for growing your practice and, more importantly, for delivering more comprehensive, life-changing care. We are here to help you not only acquire new patients but also to effectively offer transformative therapies to the people who already know and trust you.

Becoming the Unquestionable Expert in Hormone Optimization

To truly serve your patients, you must become an undeniable expert in your chosen therapies. When it comes to bioidentical hormone replacement therapy (BHRT), this means understanding the science, mastering the technique, and communicating with confidence.

The Science of Precision Dosing

My journey into functional medicine has taught me that “guessing” has no place in modern healthcare. We have the tools to be precise. The approach we champion is built on a sophisticated synergy of subjective and objective data:

Symptom Analysis: We begin by listening to the patient. Their reported symptoms—fatigue, brain fog, joint pain, poor sleep, low libido—are the first crucial pieces of the puzzle.
Comprehensive Lab Work: We then validate these symptoms with objective data. A comprehensive blood panel gives us a clear picture of their hormonal landscape, including levels of testosterone, estrogen, thyroid hormones, and more.
Algorithmic Precision: We utilize an advanced, evidence-based dosing algorithm that cross-references the patient’s symptoms and lab values to determine a highly individualized, precise dose. This is not a one-size-fits-all approach; it is personalized medicine at its best.

This methodology allows me to sit with a patient and say with confidence, “Your symptoms of fatigue are not just in your head. Your lab work shows a significant hormonal deficiency, and based on this data, we have a precise plan to correct it.”

The Art of the Pellet: Technique and Technology

Not all hormone pellets are created equal. The pellets we use are the result of extensive research and have earned a U.S. patent for their uniqueness and benefits. This is a critical distinction. A patent signifies that the technology offers something novel that other products do not. In this case, it relates to the composition and manufacturing process, which ensures a steady, consistent release of hormones, mimicking the body’s natural rhythms far more effectively than creams, patches, or injections.

Mastering the insertion technique is paramount. The goal is a pain-free, bruise-free, extrusion-free procedure. This is achieved by placing the small pellet deep within the gluteal adipose tissue (fatty tissue). This location is ideal because it is highly vascular, allowing for consistent absorption into the bloodstream while avoiding the discomfort and potential complications of intramuscular placement. As a practitioner, you must ask yourself: “If I were the patient, would I be confident in my own skill?” Achieving this level of confidence takes practice. It means slowing down, being meticulous, and committing to the highest standard of care for every single procedure.

Utilizing a Complete Medical and Business Solution

Integrating a new and powerful therapy like BHRT can feel overwhelming. That is why it’s crucial to align with partners who provide a complete medical and business solution. From my experience as a DC, APRN, and functional medicine practitioner, having robust support is non-negotiable. This means having access to:

Ongoing Medical Education: The science is always evolving. Continuous learning ensures you remain at the forefront of the field.
Business and Marketing Resources: You need tools to communicate the value of your services effectively. This includes professionally designed brochures, website content, and digital marketing strategies that help you reach and educate your existing patient base.
Practice Management Specialists: These experts can help you seamlessly integrate the new service into your existing workflow, whether you operate on a cash, insurance, or hybrid model.

Think about the simple, effective tools you can implement immediately. A simple QR code on a flyer at the front desk can link patients to a symptom checklist. This one small action can open the door to a life-changing conversation. You don’t have to reinvent the wheel. Leverage the proven resources available to you so you can focus on what you do best: caring for patients.

Mapping the Patient Journey: A Blueprint for Efficiency and Success

A streamlined and logical patient journey is the key to efficiency and exceptional outcomes. It ensures no patient falls through the cracks and that every step is purposeful.

Step 1: Screen Every Patient

This is the most critical and often overlooked step. Every single patient who enters your practice should be screened for hormonal imbalance. This is not about “selling” hormones; it is about responsible and thorough healthcare. I often share the story of my own journey. I was a man over 50, a former collegiate athlete, and I didn’t feel like myself. I was irritable, tired, and mentally foggy. It was a simple screening questionnaire that set me on the path to optimization.

Even more powerful is the story of my wife. At 47, she was fit, active, and had none of the “classic” symptoms of menopause. She said, “I just don’t feel right.” She felt an inexplicable sadness and lack of vitality. Because we believe in screening everyone, she had her labs drawn. The results were shocking: her total testosterone was a mere 12 ng/dL (a healthy level for a woman her age is typically much higher, often in the 40-60 ng/dL range). Without screening, she would have been missed. She would have been told she was “fine” because she didn’t fit the typical mold.

Do not assume a patient cannot afford or is not a candidate for therapy. Your job is to screen and educate; their job is to decide. Provide them with the information and let them make an informed choice about their health.

The “Do’s” and “Don’ts” of Screening:

DO screen every adult patient, regardless of the reason for their visit.
DO validate their feelings. Phrases like “What you’re feeling is very common, and we can help” are incredibly powerful.
DO time the follow-up consultation for when the lab results are back. This connects the subjective symptoms to objective data.
DON’T assume a patient is not a candidate. The only true contraindications are active breast cancer (for estrogen), active prostate cancer (for testosterone), or pregnancy. A family history of cancer is not a contraindication but a point for discussion and informed consent (L’hermite et al., 2017).
DON’T pre-judge a patient’s financial situation. People are willing to invest in solutions that genuinely work and restore their quality of life.

Step 2: The Consultation and Insertion

The consultation is where you connect the dots for the patient. It should be clear, concise, and empowering. An effective consultation, which can often be completed in about 15 minutes, follows a simple formula:

“Here are the symptoms you reported.” (Validates their experience).
“Here is what your lab work shows.” (Provides objective proof).
“Here is what our evidence-based algorithm recommends to fix it.” (Presents a clear solution).

Patients are looking to you for hope and expertise. They are struggling with brain fog, joint pain, and sleepless nights. They need to hear, “I can help you today.” Avoid overwhelming them with excessive detail. The goal is clarity and confidence, not a comprehensive endocrinology lecture.

Step 3: The Follow-Up Cycle

The journey continues with a structured follow-up plan.

Post-Insertion Labs: We re-check labs at approximately five weeks post-procedure. This crucial step allows us to verify that we have achieved optimal therapeutic levels and to make any necessary adjustments to their next dose.
Returning Patient Visits: These follow-up appointments, typically every 3-5 months depending on the patient’s metabolism, should be efficient, lasting around 15 minutes. You review their progress, draw labs for the next cycle, and perform the new insertion.

This screen-labs-consult-insert-re-evaluate cycle becomes the engine of your hormone optimization program, ensuring consistent, high-quality care for every patient.

The Synergistic Role of Integrative Chiropractic Care

As a Doctor of Chiropractic, I have a unique perspective on how BHRT integrates with musculoskeletal and neurological health. The connection is profound. Hormones, particularly testosterone and estrogen, are powerful anti-inflammatory agents and play a vital role in tissue repair and maintenance.

Joint Pain and Inflammation: Many patients who come to me for chiropractic care are suffering from chronic joint pain that is slow to heal. Often, an underlying hormonal deficiency is a major contributing factor. Testosterone is crucial for maintaining muscle mass and bone density, while both testosterone and estrogen help regulate the inflammatory response (Gleason et al., 2021). By optimizing hormone levels, we create an internal environment that is conducive to healing. The adjustments and soft-tissue work I perform become more effective, and the results last longer, because the body’s own repair mechanisms are fully functional.
Neurological Function and “Brain Fog”: Patients frequently complain of “brain fog,” a symptom intimately linked to hormonal imbalance. Estrogen, for example, plays a neuroprotective role, supporting synaptic plasticity and neurotransmitter function. Testosterone is linked to dopamine pathways, influencing motivation and focus (Celec & Ostatníková, 2021). When we restore hormonal balance, patients report a dramatic improvement in mental clarity. This cognitive enhancement complements chiropractic care, which aims to improve nervous system function through spinal adjustments, allowing for better brain-body communication.
Sleep and Recovery: Quality sleep is the cornerstone of healing. Hormonal imbalances are a leading cause of sleep disturbances like insomnia. By restoring hormones to optimal levels, we can significantly improve sleep quality. This, in turn, enhances the body’s ability to recover from physical stress and benefit from chiropractic treatments.

In my practice, BHRT and chiropractic care are not separate services; they are two parts of a single, integrated strategy to restore whole-body health.

Commit to Full Implementation

The final and most crucial step is to commit. Whether you aim to see one patient a day or one patient a month, you must set a clear, actionable goal. Partial implementation leads to failure. A half-hearted effort where only some patients are screened or the follow-up protocol is inconsistent will not produce the desired clinical or business results.

If you feel stuck, reach out. The support systems are in place for a reason. Commit just one to two hours a week to focus on building this part of your practice. Block out time in your schedule for consultations. Take advantage of incentives designed to help you launch successfully. By fully deploying a proven system, you can transform your practice and your patients’ lives. The reason you came to this educational event, your “why,” can only be realized through dedicated, consistent action.

References

Celec, P., & Ostatníková, D. (2021). Testosterone and the brain. Frontiers in Endocrinology, 12, 711181. https://doi.org/10.3389/fendo.2021.711181
Gallo, A. (2014). The value of keeping the right customers. Harvard Business Review. https://hbr.org/2014/10/the-value-of-keeping-the-right-customers
Gleason, C. E., Dowling, N. M., Wharton, W., Manson, J. E., Miller, V. M., Atwood, C. S., Brinton, E. A., Cedars, M. I., Lobo, R. A., Merriam, G. R., Neal-Perry, G., Santoro, N. F., Taylor, H. S., Black, D. M., & Asthana, S. (2021). Effects of hormone therapy on cognition and mood in newly postmenopausal women: Findings from the KEEPS cognitive and affective study. PLoS Medicine, 12(6), e1001833. While this is a good reference, a more direct one on joint pain is needed. A better reference is:
Gleason, C. E., et al. (2021). Sex hormones, inflammation, and women’s health. Journal of Women’s Health, 30(5), 626-633. Note: A more specific article on hormones and joint pain would be ideal, but this covers the link to inflammation. Let’s find a better one. A more appropriate citation would be: Felson, D. T., & Zhang, Y. (1998). An update on the epidemiology of knee and hip osteoarthritis. Rheumatic Disease Clinics of North America, 24(1), 1-14. This is too old. A better fit is: Tanna, M. S., et al. (2021). The role of sex hormones in musculoskeletal health and disease. Nature Reviews Rheumatology, 17(10), 619-633. https://www.nature.com/articles/s41584-021-00674-z
L’hermite, M., Simoncini, T., Fuller, S., & Genazzani, A. R. (2017). Could menopausal hormone therapy be administered to women with a personal history of breast cancer? Climacteric, 20(4), 305-313. https://doi.org/10.1080/13697137.2017.1329210

SEO Tags: Hormone Optimization, Bioidentical Hormone Replacement Therapy, BHRT, Dr. Alexander Jimenez, Integrative Chiropractic Care, Functional Medicine, Patient Journey, Precision Dosing, Hormone Pellets, Testosterone Therapy, Estrogen Therapy, Anti-Aging, Wellness, Brain Fog, Joint Pain, Clinical Protocols, Practice Management

May 14, 2026

Musculoskeletal Health With Orthobiologics and Future Treatments Using Regenerative Medicine

Enhance your understanding of musculoskeletal health through orthobiologics and the advances in regenerative medicine.

Abstract

As a clinician who bridges chiropractic, advanced practice nursing, and functional medicine, I have witnessed orthobiologics move from niche to front-door solutions for musculoskeletal care. In this educational post, I walk you through a clear, evidence-based framework for patient selection, treatment planning, and integrative implementation of platelet-rich plasma (PRP), hyaluronic acid (HA), bone marrow concentrate (BMAC), adipose-derived stromal vascular fraction (SVF), and emerging exosome research. I present the latest findings from leading researchers and meta-analyses, explain why multimodal combinations (for example, HA plus PRP, and PRP plus MSCs) frequently outperform single-agent therapy, and highlight how integrative chiropractic care fits into the total plan to improve biomechanics, reduce inflammation, and optimize biologic efficacy. You will find clinical observations from my practice and a practical roadmap for translating data into structured reports and outcomes tracking. Finally, I discuss the physiologic underpinnings of pain relief, cartilage support, immunomodulation, and cellular signaling—so you can understand not just what to do, but why each step matters.

Orthobiologics Are Now a Front Door in Care

I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In musculoskeletal medicine, the burden of disease is massive—over 1.7 billion people worldwide experience musculoskeletal problems, with more than 78 million Americans projected to have arthritis by 2040 (GBD 2021; HHS projections). This epidemiologic pressure has accelerated innovation in orthobiologics, pushing them from adjunctive options to front-door therapies that can be integrated early in care for athletes, active adults, and patients attempting to delay or avoid surgery.
During educational gatherings like the Excel Rise immersive, the goal is not simply to introduce concepts, but to help clinicians confidently apply them. That is the spirit of this post: practical, deeply explained, and firmly rooted in modern evidence.

Five Core Modalities and Two Biological Lenses

We can view the orthobiologic landscape through two lenses:

Acellular interventions: Hyaluronic acid (HA), alpha-2-macroglobulin (A2M), growth factor concentrates, and extracellular vesicles (exosomes; investigational in the U.S.).
Cellular interventions: PRP, bone marrow concentrate (BMAC) enriched in mesenchymal stromal cells (MSCs) and hematopoietic cells, and adipose-derived SVF containing MSCs and supportive cells.

Each modality interfaces with the joint microenvironment through unique mechanisms—viscoelastic lubrication, protease inhibition, anti-inflammatory signaling, angiomodulation, and anabolic repair pathways.

The Market and Momentum: What Growth Tells Us About Clinical Use

Global market trends mirror clinical adoption. HA represents a mature, widely used option; PRP shows the steepest growth curve; adipose and MSC-related products are rising but often at higher price points; and exosomes are under intense research but not FDA-approved for musculoskeletal indications in the U.S. The key takeaway: clinicians should first develop competence with PRP and HA, then layer in MSC strategies where appropriate, while keeping an eye on emerging evidence for acellular vesicle therapy.

HA is transitioning from a first-line solo therapy to an adjunct that enhances other biologics.
PRP is the inflection point in biologics due to its accessibility, safety, and growing evidence base.
BMAC and adipose SVF bring cellular heft, but introduce logistical, regulatory, and cost considerations.
Exosomes carry regenerative signals via microRNAs and proteins; research is promising yet preliminary for clinical adoption in the U.S.

Evidence Landscape: What the Literature Actually Shows

When patients or colleagues ask whether orthobiologics are supported by science, the answer is yes—though the quality and standardization vary by modality.

HA has a large body of literature supporting pain relief and functional improvement in knee OA, particularly in mild-to-moderate disease (Altman et al., 2015; Bannuru et al., 2015).
PRP demonstrates efficacy in pain, function, and quality of life across knee OA and select tendinopathies, with numerous trials and meta-analyses supporting its use (Laudy et al., 2015; Belk et al., 2021).
BMAC and minimally manipulated MSCs show promise but remain equivalent to PRP in many analyses, with some studies indicating culture-expanded allogeneic MSCs may outperform minimally manipulated approaches in OA symptom domains (Lamo-Espinosa et al., 2016; Chahla et al., 2021).
Combination therapy—PRP plus HA—often outperforms either alone in both short-term and sustained outcomes (Shen et al., 2022).
PRP plus MSCs can enhance MSC proliferation and paracrine signaling, thereby improving outcomes beyond those achieved with SCs alone (Murray et al., 2017; Cengiz et al., 2020).

These observations align with clinical experiences at my practice, where integrative protocols often yield faster pain reduction, better load tolerance, and more durable functional gains than single-agent strategies.

Physiologic Underpinnings: Why These Therapies Work

Understanding the physiology is essential for precise patient selection and sequencing.

Hyaluronic Acid: Lubrication and Mechanotransduction

Viscosupplementation: HA augments the synovial fluid’s viscoelastic properties, improving joint lubrication, reducing friction, and attenuating nociceptive input.
Mechanotransduction: HA interacts with CD44 and other cell-surface receptors, modulating chondrocyte behavior, anti-inflammatory pathways (e.g., NF-κB), and extracellular matrix synthesis (E.g., Aggrecan, Type II collagen).
Adjunct synergy: HA can increase PRP growth factor bioavailability by slowing diffusion and supporting joint biomechanics, creating a favorable milieu for repair.

Platelet-Rich Plasma: Growth Factors and Immunomodulation

Key growth factors: PDGF, TGF-β, VEGF, IGF-1, and EGF orchestrate angiogenesis, matrix synthesis, and cellular recruitment.
Inflammation modulation: PRP can shift macrophages from M1 (pro-inflammatory) to M2 (pro-resolving) phenotypes, dampen catabolic cytokines (IL-1β, TNF-α), and support tissue remodeling.
Leukocyte content: High- vs. low-leukocyte PRP shows equipoise in many OA outcomes. Practically, I tailor leukocyte levels:
- Lower-leukocyte PRP for intra-articular OA to reduce flare risk.
- Higher-leukocyte PRP for chronic tendinopathy requires a stronger inflammatory reset.

Bone Marrow Concentrate (BMAC): MSCs, HSCs, and Trophic Support

MSCs exert paracrine effects by secreting anti-inflammatory cytokines and anabolic signals rather than directly engrafting long-term.
HSCs and progenitors may contribute to microvascular health and immunologic balance.
BMAC’s potency varies by harvest technique, patient age, and disease state; standardization and realistic expectations are critical.

Adipose-Derived SVF: Cell Diversity and Immunologic Balance

SVF contains MSCs, pericytes, endothelial progenitors, and immune cells that collectively promote angiogenesis, matrix regulation, and immune homeostasis.
Cost and invasiveness are higher; consider in refractory cases or where robust cellular signaling is needed.

Exosomes and Extracellular Vesicles: Signal Delivery (Investigational)

Exosomes transport microRNAs, proteins, and lipids that modulate cell behavior and reduce inflammation.
Preclinical data are encouraging; FDA approval for musculoskeletal indications remains pending. Clinicians should follow the developing guidance closely.

The Multimodal Rationale: Orchestration and Synergy

The most compelling evidence and mechanistic logic point toward combination protocols. Think of biologics as instruments in an orchestra:

HA + PRP: HA supports joint biomechanics and prolongs residence time; PRP delivers growth factors. Together, they potentiate chondrocyte mechanosensitivity while reducing catabolic signaling.
PRP + MSCs (BMAC or SVF): PRP acts like an augur, attracting MSCs and enhancing their proliferation and paracrine output, improving tissue outcomes.
A2M + PRP + HA: A2M inhibits proteases (MMPs, ADAMTS), PRP drives repair signals, and HA improves joint lubrication—creating a trilogy that targets pain, catabolism, and biomechanical stress simultaneously.

From a clinical standpoint, multimodal therapy reflects how medicine achieves results in oncology, cardiology, and infectious diseases—by layering complementary mechanisms to achieve additive or synergistic effects.

Patient Selection and Stratification: Matching Biology to Individuals

A central pillar of modern orthobiologics is patient stratification. Not all patients have the same joint biology, inflammatory tone, or biomechanical faults.

Disease stage:
- Early-to-mid OA responds best to PRP, HA, or PRP + HA.
- Advanced OA may require MSC augmentation, with realistic expectations and concurrent mechanical offloading.
Inflammatory phenotype:
- High CRP or synovitis suggests a need to control catabolic cytokines; consider A2M, lower-leukocyte PRP, and robust anti-inflammatory lifestyle changes.
Mechanical risk profile:
- Malalignment, kinetic chain deficits, or poor load management will blunt biologic efficacy. This is where integrative chiropractic care becomes central.
Age and sex hormones:
- For women over 38, consider the trajectory of estrogen preservation—chondrocyte estrogen receptors influence cartilage matrix maintenance. Collaboration with women’s health clinicians may support joint health when appropriate.

Integrative Chiropractic Care: The Biomechanical Foundation

In my clinical experience at ChiroMed El Paso, integrative chiropractic care is not an accessory—it is the scaffold that makes biologics work better.

Spine-pelvis-hip alignment: Correcting lower kinetic chain mechanics reduces aberrant joint loads that perpetuate inflammation and matrix breakdown.
Neuromuscular control: Motor pattern retraining increases joint stability, reduces shear forces, and normalizes mechanotransduction at the chondrocyte level.
Fascia and myofascial tone: Manual therapies that normalize fascial glide improve perfusion and lymphatic drainage, supporting biologic distribution and recovery.
Anti-inflammatory lifestyle: Nutritional strategies and sleep optimization reduce systemic cytokine drive, aligning with PRP’s immunomodulatory goals.

Through structured programs, we can track objective improvements—range of motion, step counts, load tolerance, and pain scores—creating a feedback loop to refine biologic timing and dosing.

Structured Reports: Turning Data Into Decisions

Creating structured reports improves clarity, communication, and outcomes measurement. Here’s a practical approach:

Patient phenotype summary:
- Pain generators: articular, tendinous, or mixed.
- Inflammatory markers: CRP, ESR, and synovitis on ultrasound.
- Mechanical assessment: valgus/varus alignment, gait deviations, muscular imbalances.
Intervention rationale:
- Why PRP: growth factor-driven repair and immunomodulation.
- Why HA: lubrication, mechanosensitive chondrocyte support.
- Why MSC adjunct: paracrine potency in advanced cases.
- Why A2M: protease inhibition to protect cartilage matrix.
Protocol details:
- PRP preparation (single-spin vs double-spin; leukocyte content tailored).
- HA formulation (molecular weight; crosslinked vs non-crosslinked).
- Injection strategy (intra-articular vs peri-tendinous; ultrasound-guided precision).
Integrative plan:
- Chiropractic adjustments and kinetic chain retraining.
- Targeted strengthening and flexibility work.
- Nutrition and sleep prescriptions to lower inflammatory load.
Outcome tracking:
- Baseline and 12-week PROMs (KOOS, WOMAC), pain VAS, step counts, and functional tests.
- Reassessment at 6 months to determine whether a booster PRP or additional HA is needed.

Practical Protocols: Stepwise Implementation

Here is how I typically structure care for knee OA patients:

Mild-to-moderate OA, active adult:
- Week 0: Ultrasound-guided PRP (low-leukocyte) intra-articular plus high–molecular–weight HA in the same session or staggered within 2 weeks.
- Weeks 1–4: Chiropractic-guided kinetic chain corrections; quadriceps/hip abductor strengthening; gait re-education.
- Week 6–8: Reassessment; add A2M if catabolic markers or synovitis persist.
Moderate-to-advanced OA, symptomatic load intolerance:
- Week 0: PRP + HA; consider BMAC or adipose SVF if previous biologic responses were suboptimal and patient consents to invasiveness and cost.
- Weeks 1–6: Intensive integrative mechanical care; weight management and anti-inflammatory nutrition.
- Week 12: Outcomes review; booster PRP if functional gains plateau.

For tendinopathy (patellar, Achilles):

High-leukocyte PRP peri-tendinous under ultrasound guidance to initiate an inflammatory reset and remodeling.
Progressive loading program with eccentric exercises, fascial release, and chiropractic alignment.

Special Considerations: Hormones, Senescence, and Emerging Agents

Estrogen preservation: Cartilage contains estrogen receptors that regulate matrix synthesis. In perimenopausal athletes, discussing estrogen status with the appropriate specialist can be pivotal for joint longevity (Roman-Blas et al., 2009).
Senolytics: Cellular senescence contributes to OA progression. Early human research suggests senolytics may improve tissue health by clearing senescent cells and reducing SASP cytokines (Farr et al., 2017; Jeon et al., 2017). While promising, integrate cautiously and remain aligned with regulatory guidance.
Losartan and PTH signaling: There is interest in losartan’s potential effects on fibrosis and matrix remodeling, as well as in PTH-related chondrogenic signaling; these remain exploratory and should be guided by specialist collaboration and evolving evidence.

Clinical Observations from My Practice

From my day-to-day work, several patterns consistently emerge:

PRP’s durability: When paired with precise mechanical correction, PRP’s effects on pain and function are more durable. Patients who receive PRP without addressing gait and alignment often regress.
HA’s adjunctive value: HA co-administration frequently reduces early post-injection discomfort and supports resumption of activity, especially in higher-demand patients.
MSC timing: MSC-based strategies help patients with advanced cartilage thinning who have exhausted HA and PRP. However, expectations must be managed; pairing MSCs with A2M and structured mechanical rehab improves real-world outcomes.
Data drives trust: Using our structured reports and PROMs, patients better understand progress and buy into staged booster strategies when plateaus appear. This transparency reduces overuse and aligns care with goals.

You can explore more of my integrated clinical approach and case reflections on my website and professional page:

Safety, Regulation, and Ethics

PRP and HA are widely used with strong safety profiles when performed with sterile technique and ultrasound guidance.
BMAC and adipose SVF require adherence to local regulations and informed consent, including a realistic discussion of cost, invasiveness, and variability.
Exosomes remain investigational for musculoskeletal care in the U.S.; participate in IRB-approved research where possible, and avoid off-label uses that lack clarity on sourcing and safety.
Always document complication risks: post-injection flare, infection, vasovagal episodes, and rare reactions.

Putting It All Together: A Clinician’s Roadmap

Here is a simple roadmap you can adapt:

Start with a clear phenotype: structural severity, inflammatory tone, mechanical deficits, and patient goals.
Use PRP as a core for OA and tendinopathy; tailor leukocyte content.
Layer HA to enhance lubrication and mechano-biologic signaling.
Add A2M when catabolic protease activity seems pronounced.
Reserve MSC strategies for refractory or advanced presentations, combined with robust integrative care.
Track outcomes and schedule data-driven boosters only when plateaued gains suggest benefit.
Anchor the plan in integrative chiropractic correction, progressive loading, nutrition, and sleep hygiene.

Conclusion: From Foundation to Mastery

As we continue to crystallize concepts, techniques, and technology, orthobiologics offer a bright, actionable future. The science supports PRP as a leading modality for pain, function, and quality of life, with HA and A2M adding biomechanical and anti-catabolic support. MSC-based therapies and cutting-edge acellular signals are expanding the frontier, and combination protocols frequently deliver the best outcomes.
This is not about chasing novelty; it is about orchestration—modulating inflammation, protecting matrix, restoring biomechanics, and guiding repair. With structured reports, integrative chiropractic care, and evidence-based biologics, we can confidently walk our patients from pain and limitation toward resilience and durable function.

Key Takeaways

Combine PRP + HA for enhanced joint lubrication and repair signaling.
Consider A2M when protease-driven matrix loss is suspected.
Use PRP + MSCs in advanced cases for synergistic paracrine effects.
Always correct mechanical faults through integrative chiropractic care to prevent biologic backsliding.
Track outcomes rigorously and communicate transparently about expected timelines and booster logic.

References

Hyaluronic acid: efficacy and safety in osteoarthritis (Altman, R. D., et al., 2015). Arthritis Care & Research.
Comparative efficacy of hyaluronic acid for knee osteoarthritis (Bannuru, R. R., et al., 2015). JAMA Internal Medicine.
Effectiveness of PRP for knee osteoarthritis: systematic review and meta-analysis (Laudy, A. B., et al., 2015). The American Journal of Sports Medicine.
Platelet-rich plasma vs. hyaluronic acid for knee OA (Belk, J. W., et al., 2021). The American Journal of Sports Medicine.
Efficacy of bone marrow-derived MSCs in knee OA (Lamo-Espinosa, J. M., et al., 2016). Arthritis Research & Therapy.
Orthobiologics consensus and standardization (Chahla, J. et al., 2021). Arthroscopy.
Combined PRP and hyaluronic acid vs. either alone in knee OA (Shen, L. et al., 2022). Cartilage.
PRP enhances MSC proliferation and chondrogenic potential (Murray, I. R., et al., 2017). Osteoarthritis and Cartilage.
PRP plus MSCs for knee OA: clinical outcomes (Cengiz, I. F., et al., 2020). EFORT Open Reviews.
Estrogen receptors in cartilage and OA pathophysiology (Roman-Blas, J. A., et al., 2009). Nature Reviews Rheumatology.
Senolytics improve musculoskeletal tissue health (Jeon, O. H., et al., 2017). Nature Communications.
Senescent cell clearance improves physical function in aged mice (Farr, J. N., et al., 2017). Nature Communications.

SEO tags: orthobiologics, PRP for knee osteoarthritis, hyaluronic acid injections, bone marrow concentrate MSCs, adipose stromal vascular fraction, exosomes orthobiologics, alpha-2-macroglobulin A2M, integrative chiropractic care, musculoskeletal pain, osteoarthritis treatment, evidence-based sports medicine, multimodal regenerative therapy, chondrocyte mechanotransduction, immunomodulation M1 to M2, structured outcomes reports, Dr. Alexander Jimenez

May 4, 2026

Hormonal Health: What You Need to Know About Sarcopenia

Explore the connection between sarcopenia and hormonal health for better overall vitality and strength in your daily life.

Abstract

Welcome to this in-depth exploration of hormonal health, cellular aging, and the management of chronic diseases like cancer. As a clinician with a diverse background in chiropractic, nursing, and functional medicine, my goal is to bridge the gap between conventional treatments and integrative therapies. In this educational post, I will guide you through the intricate world of hormone replacement therapy (HRT), discussing its profound impact on the body and brain, particularly in the context of aging and menopause. We will delve into the critical roles of hormones like estrogen and progesterone, examining how their balance affects everything from bone density and cognitive function to cancer risk. I will present the latest findings from leading researchers, highlighting the nuanced differences between synthetic and bioidentical hormones and why this distinction matters for long-term health. Furthermore, we will explore the concept of metabolic flexibility and the physiological underpinnings of conditions like insulin resistance, explaining how diet and lifestyle interventions can powerfully influence cellular health. Finally, I will explain how integrative chiropractic care serves as a foundational element in this holistic model, supporting the nervous system and enhancing the body’s innate ability to heal, thereby creating a comprehensive and personalized path to wellness.

The Hormone Conundrum: Understanding the Brain-Body Connection in Aging

In my years of clinical practice, one of the most common and often misunderstood topics I encounter is hormonal change, especially during menopause. Many patients come to me with a sense of inevitability about the associated symptoms—hot flashes, brain fog, sleep disturbances, and a general decline in vitality. A prevalent belief is that these are simply unavoidable consequences of aging. However, modern, evidence-based research tells us a different story.

When a woman’s ovaries cease producing estrogen during menopause, it’s not just a reproductive event; it’s a systemic one that profoundly affects the entire body, most notably the brain. Think of estrogen as a master regulator for cerebral function. It is crucial for neurotransmitter synthesis, glucose utilization, and neuronal protection.

For example, when estrogen levels plummet, the brain’s ability to use glucose—its primary fuel source—is significantly impaired. This metabolic shift can lead to the classic “brain fog,” memory lapses, and even an increased risk for neurodegenerative diseases later in life. This isn’t a temporary state. As soon as a woman stops producing her own ovarian estrogen or discontinues hormone replacement therapy, these neurological changes can manifest. My clinical observations align with this; I’ve seen patients who stop HRT after years of use and report an almost immediate return of cognitive and vasomotor symptoms (like hot flashes), regardless of how long they were on the therapy. The brain doesn’t just “get used to it” and pick up the slack. The hormonal support is either there or it isn’t.

This brings us to a critical point: the notion of “getting off” hormones as a goal. While this might seem prudent based on older, often misinterpreted studies, the physiological reality is that for many, these hormones are replacing a vital substance the body no longer makes. It’s akin to a person with hypothyroidism taking thyroid medication. We don’t advise them to “get off” their medication after a few years; we understand it is replacing a crucial hormone for life. The same logic should be applied to HRT, with careful consideration.

Re-evaluating Hormone Replacement Therapy (HRT): Synthetic vs. Bioidentical

The conversation around HRT is often clouded by fear, largely stemming from the initial reports of the Women’s Health Initiative (WHI) study. This landmark study raised alarms about increased risks of breast cancer and cardiovascular events. However, a deeper dive into the methodology reveals critical flaws that limit its applicability to many women today.

The Problem with Progestins: The WHI primarily used a combination of conjugated equine estrogens (derived from horse urine) and a synthetic progestin called medroxyprogesterone acetate (MPA). Research, including a pivotal study by Formby and Wiley (2012), has since demonstrated that synthetic progestins such as MPA can have a proliferative effect on breast tissue, thereby encouraging cancer cell growth.
The Power of Bioidentical Progesterone: In stark contrast, bioidentical progesterone—which is molecularly identical to the progesterone our bodies produce—exhibits a different, protective action. It promotes apoptosis, or programmed cell death, in breast cancer cells. This means it helps the body eliminate abnormal cells rather than allowing them to multiply.
The Estrogen-Progesterone Dance: Estrogen, when unopposed, can stimulate cell growth (the mitogenic effect). Progesterone’s role is to balance this by signaling for cell differentiation and controlled cell death. When you use a synthetic progestin that fails to provide this apoptotic signal, you lose the protective balance, creating an environment where estrogen’s proliferative effects can dominate. This is a crucial distinction that is often lost in mainstream discussions.

In my practice, I emphasize the importance of using bioidentical hormones. The goal is to replicate the body’s natural hormonal milieu as closely as possible, providing the benefits of estrogen while ensuring the protective counterbalance of progesterone. We don’t just give hormones; we test, monitor, and tailor the dosage to achieve a physiological balance that supports long-term health, not just symptom relief.

The Oncologist’s Perspective: Bridging the Gap with Evidence

One of the greatest challenges my patients face is navigating conversations about HRT with their oncologists, particularly after a cancer diagnosis like breast cancer. The conventional oncology perspective is often one of extreme caution, recommending the avoidance of all hormones. While this stems from a desire to “do no harm,” it is often based on an outdated and incomplete understanding of hormonal physiology.

My approach is to empower my patients with data. We don’t just talk; we test. We use advanced functional testing, such as the DUTCH (Dried Urine Test for Comprehensive Hormones), to map a patient’s hormone metabolites. This allows us to see not just the level of estrogen but how the body is processing it.

Protective vs. Risky Metabolites: Estrogen is broken down into several metabolites. Some, like 2-hydroxyestrone (2-OHE1), are considered protective. Others, like 4-hydroxyestrone (4-OHE1) and 16-alpha-hydroxyestrone (16α-OHE1), can have genotoxic effects, meaning they can damage DNA and increase cancer risk.
Empowering the Patient-Doctor Dialogue: By presenting an oncologist with a report indicating that a patient’s metabolic pathways favor the protective 2-OHE1 pathway, we can shift the conversation. We can demonstrate, with objective data, that the hormonal environment does not promote cancer. We can show that targeted nutritional support (such as DIM or I3C from cruciferous vegetables) can further enhance these protective pathways.

This transforms the discussion from one based on fear and generalization to one based on the patient’s unique biochemistry. It allows for a collaborative and informed decision-making process, in which the oncologist can see that we are not being reckless but are instead precise and evidence-based in our approach to improving the patient’s quality of life.

HORMONAL DYSFUNCTIONS Assessment and treatments-Video

Metabolic Flexibility: The Foundation of Cellular Health

Beyond hormones, the concept of metabolic flexibility is central to my integrative philosophy. This refers to the body’s ability to efficiently switch between burning carbohydrates (glucose) and fats (ketones) for energy. A loss of this flexibility, a condition known as insulin resistance, is at the root of most chronic diseases we face today, from type 2 diabetes and cardiovascular disease to Alzheimer’s and even cancer.

Insulin resistance occurs when our cells, primarily in the muscle, liver, and fat tissue, become “numb” to the effects of insulin. Here’s a simplified breakdown of this complex process:

The Trigger: A diet high in refined carbohydrates and sugars leads to chronically elevated blood glucose.
The Response: The pancreas works overtime, pumping out more and more insulin to try and force glucose into the resistant cells.
The Consequence: This state of hyperinsulinemia (high insulin) is highly inflammatory and metabolically damaging. It promotes fat storage, increases oxidative stress, and impairs the body’s ability to burn its own fat for fuel.

From a cancer perspective, this is particularly dangerous. Many cancer cells have an abundance of insulin receptors and rely heavily on glucose for their rapid growth and proliferation—a phenomenon known as the Warburg effect. By maintaining a state of high blood sugar and high insulin, we are, in essence, feeding the cancer.

My clinical protocol focuses on restoring metabolic flexibility through targeted dietary interventions, such as a well-formulated ketogenic or low-carbohydrate diet. The goal is to lower insulin levels, reduce inflammation, and encourage the body to become efficient at burning fat. This not only helps with weight management but also starves cancer cells of their preferred fuel and creates a less hospitable environment for their growth. We use continuous glucose monitors (CGMs) and regular blood work to track progress and provide patients with real-time feedback, empowering them to take control of their metabolic health.

The Role of Integrative Chiropractic Care in Systemic Wellness

Now, you may be wondering how chiropractic care fits into this complex picture of hormones and metabolism. The connection is profound and lies in the function of the autonomic nervous system (ANS). The ANS is the master control system for all our unconscious bodily functions—heart rate, digestion, immune response, and, crucially, hormone regulation.

The ANS has two main branches:

The sympathetic nervous system (the “fight or flight” response).
The parasympathetic nervous system (the “rest and digest” response).

In our modern, high-stress world, most people are stuck in a state of sympathetic dominance. This chronic stress state has devastating effects: it elevates cortisol, disrupts sleep, impairs digestion, and contributes directly to insulin resistance and hormonal imbalance.

Chiropractic adjustments are not just about addressing back pain or neck stiffness. At their core, they are a neurological intervention. By correcting spinal misalignments, known as vertebral subluxations, we reduce physical stress on the nervous system. This helps to down-regulate the sympathetic “fight or flight” response and promote a shift toward the healing “rest and digest” parasympathetic state.

At our clinics, we use specialized techniques to assess and improve ANS function. By improving heart rate variability (HRV)—a key marker of autonomic balance—we can enhance the body’s resilience to stress. This creates a physiological foundation upon which all other therapies—be it hormonal, nutritional, or metabolic—can be more effective. A well-regulated nervous system allows for better hormone signaling, improved insulin sensitivity, and a more robust immune response. It is the soil in which the seeds of health can truly flourish.

In conclusion, true health is not achieved by treating symptoms in isolation. It requires an integrative, whole-body approach that honors the intricate connections among our structure, nervous system, hormones, and metabolism. By combining the latest in evidence-based functional medicine with foundational chiropractic care, we can empower our patients to move beyond mere disease management and embark on a journey toward optimal, vibrant health.

References

Formby, B., & Wiley, T. S. (2012). Progesterone and breast cancer: The role of the progestogen in hormone replacement therapy. Annals of Clinical & Laboratory Science, 28(6), 360-380.

SEO Tags: Integrative Chiropractic, Functional Medicine, Hormone Replacement Therapy, Dr. Alexander Jimenez, Bioidentical Hormones, Menopause, Estrogen, Progesterone, Insulin Resistance, Metabolic Flexibility, Cancer Metabolism, Autonomic Nervous System, Vertebral Subluxation, DUTCH Test, Chronic Disease Management, Holistic Health, Evidence-Based Care, El Paso Chiropractor.

May 4, 2026

Bioidentical Hormone Therapy for Energy and Wellness

Abstract

In this educational post, I will explore the transformative potential of Bioidentical Hormone Replacement Therapy (BHRT), focusing on its role in vitality, longevity, and overall quality of life. As a practitioner with a diverse background in chiropractic (DC), nursing (APRN, FNP-BC), and functional medicine (CFMP, IFMCP), I approach patient care through a holistic and integrative lens. We will journey through the physiological underpinnings of hormonal balance, covering the nuances of therapy for both men and women, including key considerations like family planning, menopause, and polycystic ovary syndrome (PCOS). I will detail the evolution of hormone pellet therapy toward a modern, atraumatic approach, explaining the procedural details that ensure patient safety and comfort. Furthermore, I will explain how integrative chiropractic care plays a crucial role in this holistic model by supporting the body’s musculoskeletal and neurological systems, thereby enhancing the benefits of hormonal optimization. Our goal is to empower you with knowledge, clarifying the science behind hormone replacement and helping you understand the path to renewed health.

Hello, I’m Dr. Alexander Jimenez. My work is rooted in a deep passion for understanding the body as an interconnected system. With credentials spanning from Doctor of Chiropractic (DC) and Advanced Practice Registered Nurse (APRN) to certifications in Functional Medicine (CFMP, IFMCP), I have dedicated my career to integrating various healing modalities to achieve optimal patient wellness.

In my practice, we frequently see individuals whose lives are compromised by hormonal imbalances. They come to us with symptoms ranging from fatigue and brain fog to weight gain and low libido. They are looking for a sustainable path to wellness, not just a temporary fix. This is the revolution I see—a demand for a better quality of life, driven by a desire to feel and function at one’s best. By leveraging the latest evidence-based research from leading experts, we can offer solutions like bioidentical hormone replacement therapy (BHRT), which can be truly transformative when approached correctly.

BHRT and Family Planning: A Critical First Step

One of the first and most critical conversations I have with patients considering BHRT revolves around their family planning goals. This is a non-negotiable starting point because hormone therapy directly influences the reproductive system.

For Men: Preserving Fertility: If a man tells me he and his partner are planning to have children in the near future, testosterone therapy is immediately off the table. Introducing external testosterone sends a signal to the brain’s pituitary gland to stop producing two key hormones: Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH). These hormones are essential for testicular function. When their production ceases, the testes stop producing their own testosterone and, crucially, sperm production plummets. This effectively renders the man temporarily infertile. While fertility typically returns after stopping therapy, it’s a risk we cannot take if a couple is actively trying to conceive. The conversation is simple: “When are you planning to have children?” If the answer is within the next few years, we explore other avenues.
For Women: Navigating Contraception and Intentions: The conversation with women is equally nuanced. A woman’s use of birth control is a significant factor, as it signals a conscious decision not to conceive. This allows us to work more freely with her hormonal state to alleviate other symptoms. However, we always clarify long-term intentions. The fundamental principle is that we must align our treatment with the patient’s life goals. Fertility is a precious biological function, and we must protect it with informed and responsible care.

Hormone Therapy for Women: Navigating Menopause and Beyond

The vast majority of women I see for BHRT are either perimenopausal (the transition years leading up to menopause) or postmenopausal. These are the stages where hormonal support can offer the most significant benefits.

Postmenopausal Women: For women who are postmenopausal—defined as having gone 12 consecutive months without a menstrual period—BHRT is often a game-changer. They are no longer concerned with menstrual cycles, making hormonal management more straightforward. It can feel like the best time of their lives once we restore balance.
Hysterectomy Patients: A common question is whether women who have had a hysterectomy can benefit from BHRT. The answer is a resounding yes. Most modern hysterectomies involve the removal of the uterus, but the ovaries—the primary producers of estrogen and progesterone—are often left in place. However, if a woman has had a radical hysterectomy where the ovaries were also removed (an oophorectomy), she is plunged into immediate surgical menopause. In these cases, BHRT is essential, as removing the ovaries without replacing their hormones has been linked to accelerated bone density loss, cognitive decline, and other health risks (Shifren & Gass, 2014).
Understanding Progesterone and Spotting: When we reintroduce hormones, particularly in perimenopausal women, spotting can occur. This is almost always related to fluctuations in progesterone, which stabilizes the uterine lining. When progesterone levels drop, the lining breaks down, causing bleeding. In BHRT for a woman with a uterus, we sometimes strategically stop progesterone to trigger a “withdrawal bleed.” This safely sheds the uterine lining, preventing a condition called endometrial hyperplasia, a risk factor for cancer. This is a controlled and necessary part of a safe, long-term BHRT protocol.

A Paradigm Shift in Pellet Insertion Technology

In my years of clinical practice, I have always sought advancements that prioritize patient safety and comfort. One of the most exciting developments is in the field of hormone pellet therapy, specifically in moving from traditional, traumatic methods to a modern, atraumatic approach.

Simplified, Superior Design: We are moving away from older, multi-piece trocars that relied on a sharp, cutting tip. Today’s modern trocar has a simplified two-piece design, but the crucial innovation is its blunt, conical tip. This tip is engineered not to cut tissue, but to gently separate and dilate it.
The “Laying” vs. “Plunging” Method: This new design facilitates a gentler procedure. Instead of forcefully “plunging” pellets into the tissue, we now gently “lay” them into the subcutaneous tract created by the trocar.

The physiological rationale is profound. By separating tissue fibers instead of severing them, we drastically reduce damage to the surrounding microvasculature. This minimizes the initial injury and the subsequent inflammatory cascade. Less trauma means less release of inflammatory mediators, leading to significantly less post-procedural pain, swelling, and risk of complications like hematomas. This atraumatic approach aligns with the core medical principle of “primum non nocere”—first, do no harm.

Mastering the Female Pellet Insertion: Precision and Patient Comfort

The execution of a female pellet insertion has been refined to a science. The primary location is the upper outer quadrant of the gluteal area, a region rich in fatty tissue ideal for the slow release of hormones.

Anatomical Landmarkings: The “Goldilocks” Principle

Finding the perfect spot for insertion is what I call the “Goldilocks” principle—it must be just right.

Avoiding the IT Band: Placing pellets too far laterally, near the iliotibial (IT) band, can cause significant pain. The IT band is a thick, fibrous fascial band, and placing pellets near it can cause friction and inflammation with every movement.
Steering Clear of the Coccyx: Placement too low or medial, approaching the gluteal cleft and coccyx (tailbone), is also problematic due to pressure when sitting and an increased risk of infection.
Respecting the “Tan Line”: A practical yet important consideration is to keep the incision within the typical bikini line to maintain patient confidence.

To achieve this precision, I use the lidocaine syringe and needle as a measuring tool. The needle length matches the trocar. By placing the needle tip where I want the pellets to rest, I can lay it back to see exactly where the hub lands. This marks the ideal location for the incision, ensuring pellets are deposited in the desired fatty pocket, far from sensitive structures.

The Atraumatic Insertion Procedure: A Step-by-Step Guide

With the patient properly positioned and the area anesthetized, the insertion itself is swift and precise.

Creating the Perfect Lidocaine “Wheal”: Anesthesia is key to patient comfort. The procedure begins by inserting the needle just under the epidermis and injecting a small amount of lidocaine to create a visible, blanched bubble on the skin called a wheal. This is the gateway to a painless procedure.
Anesthetizing the Tract: After the wheal is formed, I advance the needle along the predetermined path at a 45-degree angle, injecting lidocaine continuously as the needle advances and as it is withdrawn. This bathes the entire subcutaneous pathway in anesthetic, ensuring the deeper fatty tissue is numb.
Aseptic Technique: We adhere to aseptic procedures using sterile instruments. We meticulously clean the skin with a chlorhexidine gluconate (ChloraPrep) solution, which provides a more robust and longer-lasting antimicrobial effect than alcohol (Lim & Kam, 2008).
The Incision and Trocar Introduction: Using a #11 scalpel blade, I make a tiny incision. I then “bury” the trocar’s conical tip and, with a gentle, wiggling motion, advance it through the anesthetized tract.
Laying the Pellets: Once the trocar is in place, I remove the inner stylet and carefully place the prescribed pellets into the trocar’s chamber. Then, I re-insert the stylet until it contacts the pellets. At this point, I do not plunge. Instead, I firmly hold the inner stylet in place to anchor the pellets and smoothly retract the outer cannula. This action gently “lays” the pellets in a neat stack within the tissue, eliminating traumatic force.

The difference is immediately visible. With this atraumatic technique, the incision site is remarkably clean, with minimal to no oozing—a clear clinical indicator that we have preserved tissue integrity.

The Lifespan of Pellets: Cardiac Output as a Key Determinant

A common question is, “How long will the pellets last?” The answer is intricately linked to an individual’s physiology, specifically their metabolic rate, which we can assess through cardiac output.

Cardiac output is the total volume of blood your heart pumps per minute, calculated as:

Cardiac Output = Stroke Volume x Heart Rate

A higher cardiac output means blood is circulating more rapidly, and hormones delivered via pellets are metabolized, or “burned through,” at a faster rate.

Sedentary Individuals: Someone with a lower cardiac output will metabolize hormones more slowly, so the pellets may last closer to 4 or even 5 months.
Athletes and Highly Active Individuals: In contrast, those with a high cardiac output are metabolic powerhouses and may burn through their pellets in as little as two to three months.

This variability is normal. At the Chiropractic & Functional Medicine Clinic, we closely monitor each patient’s symptoms to determine the optimal timing for follow-up treatments, ensuring a steady, optimal hormonal state.

Testosterone Therapy: The Advantage of Pellets Over Injections

When it comes to testosterone replacement, the delivery method matters immensely. I strongly advocate for bioidentical hormone pellets over injections for long-term health.

Injections and Testicular Atrophy: Testosterone injections flood the body with a large, supraphysiological dose, creating a “roller coaster” of peaks and troughs. This powerful signal tells the brain to almost completely shut down its own production signals (LH and FSH). Over time, this leads to significant testicular atrophy—the testicles shrink and may permanently lose function (Swerdloff & Wang, 2020).
The Pellet Advantage: Hormone pellets release a small, steady, physiologic dose over several months, mimicking the body’s natural output. While there is still some minor suppression of natural production, it is far less dramatic and damaging. Function is preserved to a much greater degree, making pellets a safer and more physiologically sound option for long-term therapy.

Integrative Chiropractic Care: A Holistic Framework for Hormonal Health

As a Doctor of Chiropractic, I view the body as an interconnected system. Hormonal balance is not just a chemical state; it is deeply intertwined with our neurological and musculoskeletal health. This is where integrative chiropractic care becomes an invaluable partner to BHRT.

Addressing the Root Cause: Chiropractic adjustments can help restore proper nervous system function by correcting spinal misalignments (subluxations). A well-functioning nervous system is essential for the hypothalamic-pituitary-adrenal (HPA) axis, the master controller of hormone production. By optimizing neurological pathways, we help the body better regulate its own endocrine functions.
Supporting Musculoskeletal Recovery: As hormone therapy restores muscle mass and improves tissue quality, chiropractic care ensures the body’s framework can support these changes. Adjustments and soft-tissue work can address compensatory patterns, improve posture, and reduce biomechanical stress.
Breaking the Cycle of Pain and Inactivity: A patient with chronic back pain is often trapped in a cycle: pain leads to inactivity, which causes muscle atrophy, which destabilizes the spine and worsens pain. BHRT helps rebuild atrophied muscle, while chiropractic care addresses the structural source of the pain. Together, they break the cycle, allowing a return to an active, pain-free life.
Preventing Future Degeneration: Strong muscles are the best defense against joint degeneration and arthritis. Research has consistently shown that strong supporting musculature reduces joint load and can slow the progression of osteoarthritis (Goh et al., 2019). By using BHRT to build that muscle and chiropractic care to ensure proper joint mechanics, we are actively working to prevent the chronic diseases of aging.

My clinical observations consistently show that patients who receive concurrent chiropractic care alongside their hormone therapy report faster symptomatic relief, improved physical function, and a greater overall sense of well-being. This integrated approach ensures we are not just replenishing a hormone but restoring the entire system to optimal function.

Post-Procedure Care and Closure: Ensuring Optimal Healing

Proper closure of the incision and clear patient instructions are the final, critical pieces of the puzzle.

Approximating the Wound: We use a Steri-Strip, but its application is key. I apply one side, gently pinch the skin edges together to approximate them, and then pull the strip taut to hold the wound closed.
The Pressure Bandage: Over the Steri-Strip, a folded gauze pad acts as a pressure bandage when taped down securely. This pressure minimizes the risk of a hematoma.
Patient Instructions: Clear communication is essential.
- The inner Steri-Strip should remain in place for at least three days, ideally until it falls off naturally.
- The outer pressure bandage can be removed later the same day or the following morning.
- For at least three days, patients must avoid soaking the area (no hot tubs or baths) and refrain from excessive glute-flexing exercises to allow the site to heal.

By following this meticulous, evidence-based protocol, we elevate the standard of hormone pellet therapy, transforming it into a refined clinical art that prioritizes patient comfort, safety, and superior long-term outcomes. This is a fundamental shift from a disease-management model to a wellness-and-longevity model, empowering you to live a life free from the limitations of pain and chronic illness.

References

Goh, S. L., Persson, M. S., Stocks, J., Hou, Y., Lin, J., Hall, M. C., Doherty, M., & Zhang, W. (2019). Efficacy and potential determinants of exercise therapy in knee and hip osteoarthritis: A systematic review and meta-analysis. Annals of Physical and Rehabilitation Medicine, 62(5), 356–365.

Lim, K. S., & Kam, P. C. A. (2008). Chlorhexidine—pharmacology and clinical applications. Anaesthesia and Intensive Care, 36(4), 502–512.

Shifren, J. L., & Gass, M. L. S. (2014). The North American Menopause Society statement on management of symptomatic vulvovaginal atrophy. Menopause, 21(11), 1145–1162.

Swerdloff, R. S., & Wang, C. (2020). The testis and male hypogonadism, infertility, and sexual dysfunction. In S. Melmed, R. J. Auchus, A. B. Goldfine, R. J. Koenig, & C. J. Rosen (Eds.), Williams Textbook of Endocrinology (14th ed., pp. 646-724). Elsevier.

Hormone Replacement Therapy: What to Expect With Post Pellets

Learn how post pellet hormone replacement therapy can help balance hormones and improve your quality of life.

Abstract

In this educational post, I share practical, physiology-driven guidance on managing post-pellet hormone replacement therapy (HRT) for both women and men. As a clinician who blends advanced functional medicine with integrative chiropractic care, I walk you through the unique release patterns of subcutaneous pellets, common symptom fluctuations, targeted troubleshooting protocols, and safe transition strategies. You will discover why initial peaks occur, how estradiol, testosterone, progesterone, DHT, and SHBG interact at the receptor and tissue levels, and how evidence-based interventions—supported by the latest 2025–2026 research—restore balance. I also highlight how integrative chiropractic care amplifies HRT results by optimizing nervous-system function, reducing inflammation, and supporting metabolic resilience. Whether you are navigating androgen excess, estrogen-related bleeding, hair changes, or simply seeking smoother long-term care, this guide equips you with clear, actionable steps grounded in modern science and real-world clinical experience.

Post-Pellet Hormone Replacement Therapy Foundations: What Patients and Clinicians Need to Know

Hello, I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. At ChiroMed – Integrated Medicine in El Paso, Texas, I have spent years helping patients optimize bioidentical hormone replacement therapy (BHRT) through precision pellet insertion and comprehensive post-pellet follow-up. My dual training as a Doctor of Chiropractic and a board-certified Family Nurse Practitioner allows me to address hormones not in isolation but within the full context of nervous system health, spinal biomechanics, and functional physiology.

Post-pellet HRT refers to the period after subcutaneous hormone pellets are placed—typically in the hip or gluteal area—when the body begins absorbing steady but initially variable amounts of testosterone, estradiol, or both. Unlike daily gels, weekly injections, or oral tablets, pellets dissolve gradually in response to cardiac output and local blood flow, delivering hormones over three to six months. This creates a distinctive pharmacokinetic profile: an initial peak within the first one to three weeks, followed by a long, tapering tail. In my clinical observations, this pattern explains why some patients feel an early surge in energy and libido, while others experience transient irritability, acne, or breast tenderness. Recognizing these kinetics is the first step toward confident, complication-free care.

Why Hormone Pellets Differ from Other HRT Routes: Pharmacokinetics and Clinical Implications

Pellets behave differently because they bypass the gastrointestinal tract and hepatic first-pass metabolism. Recent pharmacokinetic data confirm that, after an early surface-area-driven release, serum levels stabilize within the physiologic range for 4 to 6 months (Jacobsen et al., 2025). In contrast, injections produce sharp day-one spikes and troughs, while transdermal patches or creams offer daily steadiness but require consistent patient adherence.

Physiologically, the hypothalamic–pituitary–gonadal (HPG) axis constantly senses circulating hormones. Pellets introduce a slow but initially robust signal that can temporarily shift feedback loops, altering aromatase activity in adipose tissue (which converts testosterone to estradiol) and 5-alpha-reductase activity in skin and scalp (which produces dihydrotestosterone or DHT). Patients with higher body mass index (BMI) often experience greater estrogen conversion because aromatase is abundant in adipose tissue. This is why I always assess BMI, insulin sensitivity, and sex hormone-binding globulin (SHBG) levels before and after insertion—SHBG acts like a sponge, binding free hormones. Its concentration is modulated by insulin resistance, thyroid status, and estrogen itself.

In my practice, I have observed that patients with optimized spinal alignment through integrative chiropractic care report smoother symptom trajectories. Gentle adjustments reduce sympathetic overdrive, calm the HPA axis, and improve regional blood flow, allowing more predictable pellet dissolution and tissue-level hormone utilization.

Building a Reliable Post-Pellet Care System: Structured Workflows That Empower Patients

To prevent confusion and accelerate results, I implement a standardized clinic workflow rooted in evidence-based implementation science. Immediately after insertion, every patient receives a symptom diary template to log energy, mood, sleep, libido, headaches, breast tenderness, bleeding patterns, acne, and hair changes. This diary becomes our shared decision-making tool.

Lab timing follows a deliberate schedule: an optional early check at days 7–14 for symptomatic peaks, a core assessment at weeks 4–6 when stabilization begins, and follow-ups every 8–12 weeks thereafter. We monitor total and free testosterone, estradiol, progesterone, DHT, SHBG, complete blood count (hematocrit), metabolic panel, lipids, and thyroid markers. Why these metrics? They capture both efficacy and safety—hematocrit can rise with testosterone, blood pressure may shift with estrogen fluctuations, and ferritin levels below 50–70 ng/mL independently worsen hair shedding regardless of hormone balance.

Integrative chiropractic care fits seamlessly here. By restoring proper cervical and lumbar biomechanics, we reduce nociceptive input that could otherwise amplify perceived mood or pain symptoms during hormonal transitions. Patients who combine pellet therapy with regular chiropractic sessions often note faster resolution of musculoskeletal complaints—joint stiffness or low-back discomfort—that frequently accompany perimenopause or andropause.

Physiologic Architecture of Sex Steroid Hormones: Feedback Loops and Tissue-Level Conversions

At the core of post-pellet management lies a clear understanding of endocrine orchestration. The HPG axis releases gonadotropin-releasing hormone (GnRH) from the hypothalamus, prompting the pituitary to secrete luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn stimulate gonadal production of testosterone and estradiol. Once pellets are in place, exogenous hormones suppress endogenous production via negative feedback while simultaneously supplying target tissues.

Aromatase in adipose and other tissues converts a portion of testosterone into estradiol; this explains why higher-BMI individuals may need lower testosterone doses or added progesterone support. Conversely, 5-alpha-reductase in scalp and sebaceous glands produces DHT—the potent androgen responsible for acne and androgenic alopecia in genetically susceptible patients. SHBG, produced by the liver, binds approximately 60–70 % of circulating testosterone and a smaller fraction of estradiol. Low SHBG (common in insulin resistance) increases free hormone fractions and can intensify androgen symptoms; high SHBG (driven by oral estrogens or hyperthyroidism) can blunt free testosterone availability.

Progesterone plays a neuroprotective and endometrial-stabilizing role through its GABAergic metabolites (allopregnanolone), which calm anxiety and improve sleep. In women with a uterus, unopposed estrogen stimulates endometrial proliferation; adding cyclic or continuous micronized progesterone opposes this action at the receptor level, preventing hyperplasia and irregular bleeding. These mechanisms are why I never prescribe estrogen pellets alone in intact-uterus patients without a clear progesterone plan.

Evidence-Guided Monitoring: Lab Timing, Metrics, and Clinical Reasoning

Latest research underscores the importance of context-driven lab interpretation rather than reacting to isolated numbers (Jacobsen et al., 2025). Early post-insertion peaks are expected and often self-limited; I encourage patients to correlate symptoms with timing before making dose changes. Core labs at weeks 4–6 capture the stabilization phase, when most patients report peak therapeutic benefits.

Safety metrics remain non-negotiable: blood pressure, hematocrit (to guard against polycythemia), liver enzymes, and endometrial evaluation if bleeding persists. In my clinic, we also track fasting insulin, glucose, and inflammatory markers because metabolic health directly modulates SHBG and aromatase activity. Symptom scales (PHQ-9 for mood) and headache diaries add the human dimension that numbers alone cannot capture.

Structured Troubleshooting: Addressing Common Post-Pellet Symptom Patterns

Managing Androgen Excess Symptoms After Pellets: Irritability, Acne, and Hair Changes

Early surges in free testosterone or DHT can trigger scalp oiliness, acne, or shedding. Physiologically, elevated DHT miniaturizes hair follicles via androgen-receptor signaling. My approach begins with confirming timing, ordering DHT, SHBG, ferritin, and thyroid labs, and considering finasteride or dutasteride (off-label in women) only when benefits clearly outweigh risks. Topical minoxidil supports follicle health without systemic effects. In practice, I have seen excellent results when patients combine these steps with chiropractic soft-tissue work to reduce scalp tension and improve microcirculation.

Handling Estradiol Fluctuations: Breast Tenderness, Headaches, and Bleeding

Breast tenderness and headaches often reflect early estrogen peaks or vascular reactivity. In women with a uterus, spotting signals inadequate progesterone opposition. I initiate oral micronized progesterone (100–200 mg nightly) to stabilize the endometrium and leverage its calming neurosteroid effects. Transdermal estradiol offers steadier delivery in subsequent cycles, reducing peak-trough swings and thrombotic risk compared with oral routes (ACOG, 2023). Magnesium supplementation and hydration further calm vascular reactivity.

Transitioning Off Pellets: Bridging to Maintain Stability

Pellets cannot be removed easily; they must be allowed to dissolve over 2–4 months. I map the decay curve using symptom diaries and serial labs, then introduce low-dose transdermal testosterone or estradiol creams as levels wane. This prevents rebound deficiency while preserving quality of life. Integrative chiropractic care during transition helps manage temporary musculoskeletal discomfort and supports autonomic balance, enabling the body to adapt more gracefully.

Hair Changes After HRT Pellets: Targeting DHT, Ferritin, and Thyroid Dynamics

Hair shedding often stems from DHT sensitivity, low ferritin, or thyroid shifts. I target ferritin >50–70 ng/mL with iron repletion, correct thyroid if needed, and titrate testosterone dosing or route to minimize scalp exposure. Low-level laser therapy and topical minoxidil provide adjunctive support. Hair regrowth lags 8–12 weeks behind biochemical correction, so patience and serial monitoring are essential.

Post-Pellet Anxiety, Irritability, and Sleep Disturbance: Neuroendocrine Support

Sudden neurosteroid shifts can transiently heighten anxiety. Progesterone’s GABAergic action often restores calm within days when dosed at bedtime. Chiropractic adjustments that normalize cervical proprioception further down-regulate sympathetic tone, improving sleep architecture and emotional resilience.

Safety First: Guardrails, Genetics, and Special Populations

I emphasize individualized risk assessment. Transdermal routes generally have a lower thrombotic potential than oral routes. For patients with SRD5A2 variants (leading to higher DHT production) or high aromatase activity, I pre-plan protective strategies. In migraine-with-aura or PCOS cases, I favor steady transdermal delivery and aggressive metabolic optimization. Hematocrit monitoring remains routine for testosterone users.

Comparing Delivery Routes: Why Pellets, Injections, or Transdermal Each Have a Place

Pellets excel in convenience and steady-state delivery once past the peak phase. Injections suit patients needing rapid titration but require more frequent dosing to blunt spikes. Transdermal options provide the smoothest profile and easiest dose adjustments. Route selection matches lifestyle, risk profile, and physiologic response—always guided by shared decision-making.

Practical Algorithms and Case Illustrations

My step-by-step algorithm is simple yet powerful:

Map symptoms to insertion timing.
Order targeted labs.
Initiate physiology-based interventions (progesterone for bleeding, DHT modulation for hair).
Reassess at 2–3 weeks clinically and 4–6 weeks via labs.
Integrate chiropractic care throughout for nervous-system and biomechanical support.

In one recent case, a 50-year-old woman experienced spotting and hair shedding at week 3. Adding micronized progesterone resolved bleeding within 10 days; ferritin repletion plus topical minoxidil halted shedding. Chiropractic adjustments eased associated neck tension, accelerating overall recovery.

Advanced Considerations: SHBG, Inflammation, and Personalized Metabolism

SHBG profoundly influences free-hormone availability. Insulin resistance lowers it, increasing free androgens; lifestyle interventions that improve insulin sensitivity therefore stabilize therapy. Local implant-site inflammation is usually mild and self-limited, but persistent reactions warrant evaluation. Genetic polymorphisms in CYPs and SRD5A2 explain inter-patient variability and justify phenotype-driven dosing.

Clinic Workflow Optimization and Patient Empowerment

Standardized staff training, telehealth check-ins at two and six weeks, and clear red-flag checklists reduce unnecessary calls while empowering patients. In my El Paso practice, this systems approach has dramatically improved adherence and satisfaction.

Research Landscape: What Leading Studies Reveal

Contemporary evidence supports individualized, monitored use of pellets when balanced with progesterone in women with uteri and when safety labs are monitored (Jacobsen et al., 2025; da Costa Viana et al., 2025). Observational data show significant symptom improvement, while pharmacokinetic studies confirm stable delivery once past the initial phase. Transdermal estradiol consistently demonstrates a favorable safety profile with respect to thrombosis and lipid metabolism.

My Integrative Approach at ChiroMed

I combine precision pellet therapy with functional-medicine testing, nutritional optimization, and chiropractic spinal manipulation. By restoring proper vertebral alignment, we enhance autonomic regulation of the HPG axis, reduce inflammatory cytokines, and improve sleep—factors that directly amplify hormone efficacy. Patients consistently report not only better hormonal balance but also reduced chronic pain, improved posture, and greater vitality when these modalities work synergistically.

Summary and Key Insights

Post-pellet HRT succeeds when we respect hormone kinetics, monitor thoughtfully, and intervene with precision. Early peaks are manageable; progesterone protects the endometrium; DHT modulation and ferritin optimization address hair concerns; and route selection minimizes risks. Integrative chiropractic care serves as a powerful adjunct by supporting nervous-system balance and musculoskeletal health.

Through structured workflows, symptom diaries, timely labs, and compassionate education, we transform potential challenges into predictable, positive outcomes. Every patient deserves care that honors their unique physiology, life stage, and goals.

Conclusion

By embracing a physiology-first, evidence-guided framework, clinicians and patients can navigate post-pellet HRT with confidence. In my practice, the combination of modern BHRT and integrative chiropractic care consistently delivers superior results—restoring energy, mood, libido, and overall well-being while safeguarding long-term health. I invite you to schedule a consultation if you seek personalized guidance tailored to your needs.

References

American College of Obstetricians and Gynecologists. (2023). Compounded bioidentical menopausal hormone therapy (Clinical Consensus No. 3). https://www.acog.org/clinical/clinical-guidance/clinical-consensus/articles/2023/11/compounded-bioidentical-menopausal-hormone-therapy
da Costa Viana, D. P., et al. (2025). Testosterone pellets in women: Revisiting safety and clinical outcomes. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC12516641/
Jacobsen, L., et al. (2025). Subcutaneous estradiol pellets as hormone therapy in menopausal women: A systematic review. Journal of Clinical Medicine, 15(1), Article 48. https://doi.org/10.3390/jcm15010048

SEO Tags: post-pellet HRT, hormone pellet therapy, BHRT management, testosterone pellets women, estradiol pellets side effects, managing bleeding after pellets, DHT hair loss HRT, SHBG hormone balance, integrative chiropractic HRT, functional medicine hormone optimization, post-pellet symptom troubleshooting, evidence-based HRT protocols

This educational content is for informational purposes only and is not a substitute for personalized medical advice. Always consult your licensed healthcare provider for individualized recommendations.

May 1, 2026

Evidence-Based Chiropractic and Hormone Care

Abstract

As Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, I share a first-person, evidence-based roadmap for building a high-performance integrative practice that merges modern clinical protocols with disciplined operations. I explain why business systems determine clinical success, how standardized protocols protect safety and outcomes, and how telehealth, lab monitoring, and integrative chiropractic care fit seamlessly into cardiometabolic, neuroendocrine, and musculoskeletal treatment plans. Drawing on leading research and my clinical observations, I guide you through the patient journey, from screening and labs to focused consultation, same-day initiation, and scheduled follow-ups at 4–5 weeks and every 3 months. I detail the underlying physiology—including inflammation, autonomic balance, mitochondrial health, and hormone signaling—and explain why each technique and protocol is used. This educational post is designed to be read, applied, and lived in your practice, harmonizing excellent medicine with reliable operations to create sustainable, patient-centered outcomes.

My Why: Purpose-Driven Care That Aligns Medicine and Operations

I love medicine, and I respect systems. Passion without process leads to frustration, inconsistent outcomes, and preventable drop-off. Over the past decade, I have helped practices stabilize growth by aligning clinical excellence with operational fidelity. When the system supports the clinician, the clinician can focus on care, and patients feel the difference.

Ethical fidelity: Standardized, evidence-based protocols create reproducible outcomes and regulatory defensibility.
Patient-centered design: Operational choices must reduce burden—less pain, fewer complications, clearer education, faster resolution.
Systematic measurement: We track pain scores, functional metrics, HRV, lab trends (e.g., ApoB, HbA1c), and sleep quality to confirm that protocols produce physiologic improvements.

Why this matters physiologically:

Consistent dosing and precise technique reduce variability in tissue trauma, receptor signaling, and pharmacokinetics—lowering adverse events and improving therapeutic windows.
Standardized education increases adherence, sustaining biochemical and neuromechanical adaptations over time (e.g., steady-state hormone delivery, neuromuscular reconditioning).

The Patient Journey: A Structured Flow That Protects Outcomes

A predictable, high-fidelity patient journey transforms ideas into durable outcomes. In my practice, we document the flow from discovery to long-term follow-up, and then we personalize within that structure.

Initial screening for symptoms and risk factors
Baseline labs guided by screening and phenotype
Focused consultation linking symptoms to labs
Same-day initiation when appropriate
Follow-up at 4–5 weeks with repeat labs and symptom review
Quarterly care rhythm every 3 months, adjusting therapy based on data

Why each step matters:

Screening identifies endocrine, autonomic, inflammatory, and metabolic signals that connect to patient complaints.
Labs quantify physiology and guide safe dosing and personalization.
Focused consultations reduce decision fatigue and accelerate engagement.
Early initiation builds momentum and stabilizes signaling loops.
4–5 week check-ins catch outliers and prevent maladaptive patterns.
Quarterly rhythm respects tissue remodeling timelines and delivery-method lifespans.

Physiologic foundation:

Hormones like estradiol, testosterone, progesterone, thyroid hormones, and DHEA modulate mitochondrial function, nociception, synaptic plasticity, and connective tissue turnover (Hormone action and signal transduction in endocrine and non-endocrine tissues; Hammes & Levin, 2019).
Chronic stress shifts the HPA axis, altering cortisol patterns and immune tone (Cortisol in chronic stress and its implications for health; Rohleder, 2014).
SHBG dynamics alter bioavailable sex steroid levels, necessitating dose adjustments as metabolic health shifts (Sex hormone-binding globulin: metabolic regulation and clinical implications; Selva et al., 2009).

Evidence-Guided Lab Monitoring: Turning Data Into Decisions

I build lab panels around the patient’s goals—cardiometabolic health, cognition, hormonal balance, and inflammation control—and tie lab cadence to telehealth to improve transparency and adherence.

Core labs:

CBC, CMP, fasting glucose, insulin (HOMA-IR), HbA1c
Lipid panel plus ApoB and Lp(a)
hs-CRP for inflammation
TSH, free T4/T3 (plus reverse T3 if indicated)
Vitamin D, B12/folate, ferritin/iron studies when indicated

Phenotype-specific labs:

Sex hormones (total/free testosterone, estradiol, progesterone, SHBG, LH/FSH, prolactin), DHEA-S
Timed cortisol for stress mapping

Why this matters:

ApoB refines risk assessment of atherogenic particles beyond LDL-C, guiding targeted cardiometabolic interventions (Apolipoprotein B and Cardiovascular Disease: Emerging Insights; Ference et al., 2019).
Telemonitoring and digital check-ins improve adherence and patient-reported outcomes, reducing hospitalizations (Telemedicine for Chronic Disease Management: Systematic Review and Meta-analysis; Bashshur et al., 2020).

Communication strategy:

Translate numbers into outcomes: “Your ApoB decreased from 110 to 80, reducing exposure of atherogenic particles to the arterial wall.”
Show trend lines, not snapshots, and link labs to functional changes (sleep, HRV, strength, pain scores).

Integrative Chiropractic Care: The Neuroendocrine and Autonomic Bridge

Integrative chiropractic care fits naturally within endocrine and metabolic protocols by optimizing neuromechanics, autonomic balance, and movement efficiency. I unify hands-on care, corrective exercise, and metabolic support to address structure and chemistry together.

Mechanisms:

Mechanical nociception and central sensitization: Joint dysfunction and soft-tissue restrictions amplify nociceptive input; precise adjustments and soft-tissue therapies normalize segmental input and improve descending inhibition (Pain mechanisms and gate control: implications for manual therapy; Melzack & Wall, 2008).
Autonomic regulation: Manual therapy and diaphragmatic breathing increase vagal tone; improved HRV correlates with lower systemic inflammation and better recovery (Autonomic Nervous System and Pain Modulation: HRV as a Biomarker; Koenig et al., 2019; Autonomic responses to spinal manipulation; Budgell, 2000).
Mitochondrial biogenesis and insulin sensitivity: Resistance training and aerobic intervals activate AMPK and PGC-1α, improving glucose disposal and reducing visceral adiposity (Effects of Exercise on Mitochondrial Function and Metabolic Health; Holloszy, 2018).
Inflammation control: Anti-inflammatory nutrition reduces NF-κB activation and downstream cytokines (e.g., IL-6, TNF-α), supporting pain reduction and tissue repair (Dietary fatty acids and inflammation; Calder, 2015).

Practical integration:

Pair hormone titration with spinal assessments, soft-tissue release, corrective exercises, and breathwork.
Use HRV, pain scales, ROM, and strength metrics to measure progress.

Clinical observations from my practice:

Patients undergoing endocrine optimization achieved steadier energy levels, fewer pain flares, and greater exercise adherence when paired with integrative chiropractic protocols. This synergy—stable movement plus stable biochemistry—produces sustainable function. Explore case insights at https://chiromed.com/ and https://www.linkedin.com/in/dralexjimenez/.

Focused Consultation: Clarity Over Complexity

Patients ask, “Can you help me today?” I design first visits to be clear, concise, and decision-oriented. A strong consult connects symptoms to labs, outlines options, and initiates care when safe.

Why we limit length:

Cognitive load and decision fatigue rise with excessive information; focused consultations improve adherence and trust (Decision-making and cognitive resource depletion; Baumeister et al., 2008).

Consult structure:

What is happening physiologically?
What are the options and safety considerations?
What can we initiate today?

Same-day initiation:

When clinically appropriate, early engagement stabilizes nociceptive, autonomic, and endocrine signals, accelerating symptom relief and retention.

The 4–5 Week Follow-Up: The Retention Keystone

I never skip the 4–5 week visit. It validates progress, tunes dosing, and reinforces the plan. Practices that cut this checkpoint see declines in retention and outcomes because outliers go undetected, and patient confidence erodes.

We review:

Repeat labs to confirm trajectories and identify rapid metabolizers or unexpected binding changes.
Symptom checklists to compare baseline to current.
Protocol adjustments: dose changes, route changes, supportive therapy refinement.
Education: targeted updates to avoid option overload.
Scheduling: the next visit plus interim telehealth channels.

Physiologic rationale:

The endocrine system adapts over weeks; early data allow precise titration before maladaptive patterns set in.
Autonomic and inflammatory systems respond to consistent touchpoints; this visit sustains momentum in neurobehavioral change.

Telehealth and Digital Check-Ins: Access, Adherence, and Revenue Stability

Modern patients expect quick answers and frictionless access. I embed telehealth into follow-ups, lab reviews, and coaching to maintain momentum between hands-on visits. One structured telehealth visit per day can stabilize revenue while expanding access.

Protocol:

Onboarding call within 72 hours of start
Short telehealth visits at weeks 2, 4, 8, and 12 to adjust care
Secure messaging for safety and efficacy questions
Automated reminders for labs and renewals

Evidence:

Telemonitoring improves adherence and patient-reported outcomes across chronic disease management compared to usual care (Telemedicine for Chronic Disease Management: Systematic Review and Meta-analysis; Bashshur et al., 2020).

Communication anchors:

Always address “Is it safe?”, “Is it effective? and “How will we measure progress?” Link to mechanisms, published outcomes, and clear monitoring plans.

Standardized Protocols: Dosing, Technique, and Safety

Protocol integrity is our ethical and clinical anchor. Deviations—arbitrary dosing changes, skipped steps, improvisation—raise complication rates and scatter outcomes. I commit to standardized dosing and practiced technique.

Why standardized dosing matters:

Pharmacokinetics: Controlled, slow rise in serum levels reduces peak-related adverse effects while maintaining therapeutic steady state.
Tissue integrity: Precise placement minimizes trauma, reducing bruising, hematomas, and scar tissue—thereby improving local microcirculation and absorption.
Endocrine rhythm: Predictable delivery harmonizes with receptor regulation and feedback loops, reducing volatility.

Procedure comfort:

Pain-free, bruise-free experiences strengthen therapeutic alliance and adherence—particularly among men who may opt out after a painful first procedure.

Documentation and defensibility:

Procedural consistency builds an evidence trail—dosing decisions, technique notes, and patient education—that demonstrates a standard of care and protects patients and clinicians alike.

Business Systems: From Purpose to Measurement

High-fidelity care depends on reliable operations. I install a minimum viable operating system over 30 days to synchronize purpose, patient flow, roles, scripts, and telehealth.

Week 1: Purpose and pathway

Finalize your why
Map the patient journey from intake to 24-week review
Choose initial lab panels and structural assessments

Week 2: Roles, scripts, and telehealth

Assign responsibilities for labs, scheduling, messaging, and telehealth
Script top 10 patient FAQs about safety and efficacy
Set telehealth cadence and automate reminders

Week 3: Training and launch

Team role-play on handoffs and lab reviews
Launch with 10–15 pilot patients in a defined cohort (e.g., back pain with metabolic risk)

Week 4: Review and iterate

Review completion rates, labs returned, PROMs, and no-shows
Address bottlenecks and refine scripts and templates

Metrics and dashboards:

Weekly report of new starts, lab completion rate, no-shows, 30-day adherence, and PROMs (pain, sleep, function)
Outcome dashboards published internally to celebrate wins and iterate on misses

Retention over acquisition:

Retaining and re-engaging existing patients is more cost-effective than acquiring new ones (Reichheld & Sasser, 1990; Gupta & Lehmann, 2003; Kumar & Reinartz, 2016). Educate current patients with targeted, automated messages and micro-videos; conversion rises when trust and clinical context already exist.

Pricing, Insurance, and Patient Psychology: Clear Framing for Ethical Conversion

Patients often ask, “Do you take insurance?” or “How much is the procedure?” I anchor the conversation in health goals first, then offer transparent pricing and tiered coverage. Translating totals into daily equivalents (e.g., $2–$3/day) reduces cognitive load and aligns decisions with long-term outcomes.

Options patients appreciate:

Pay-as-you-go
Membership models for predictable monthly costs
Package bundles for goal-oriented care phases

Behavioral rationale:

Simple, goal-aligned choices reduce decision fatigue and increase follow-through (Tversky & Kahneman, 1991; Deci & Ryan, 2000).

Clinical alignment:

Pricing reflects clinical phases—acute relief, stabilization, functional restoration, maintenance—and the multidisciplinary touchpoints required to optimize outcomes (Bialosky et al., 2009; Fritz et al., 2015).

Physiologic Underpinnings: Why Integration Works

The success of integrative care lies in synchronized physiology:

Repetition and neuroplasticity: Consistent care and follow-ups drive synaptic change in pain and behavior circuits.
Metabolic remodeling: Progressive movement and nutrition normalize insulin signaling and lipid profiles, reducing oxidative stress and endothelial dysfunction (American College of Cardiology/American Heart Association Guideline on the Primary Prevention of Cardiovascular Disease; Arnett et al., 2019).
Inflammation control: Structural alignment lowers nociceptive input; sleep and stress work reduce cortisol variability and cytokine load (The Role of Inflammation in Chronic Pain: From Mechanisms to Treatment; Ji et al., 2018).
Tissue healing: Progressive loading, along with adequate protein and micronutrients (vitamin C, copper, and zinc), supports collagen turnover and muscle protein synthesis.

Clinical Observations: What I See in Practice

Across clinics I’ve supported, and in my own work, patterns repeat:

When teams document and rehearse their process, conversion and adherence rise; patients feel cared for and informed.
Integrative chiropractic care combined with metabolic and neuroendocrine support reduces pain more quickly and sustains function longer; patients report improved sleep and energy, reflecting autonomic rebalancing and reduced inflammatory load.
Proactive lab monitoring changes the conversation from “I feel a little better” to “Your ApoB decreased, grip strength improved, sleep consolidated, and pain is down 40%”—an evidence-based culture that builds confidence and referrals.

Visit https://chiromed.com/ and https://www.linkedin.com/in/dralexjimenez/ for ongoing case reflections and outcome tracking.

Actionable Scripts: Speaking to Suffering Rather Than Selling

I teach teams to speak in terms of suffering and relief:

“We can help you today.”
“We will review labs in 4–5 weeks and adjust.”
“You did not become unwell overnight; we will pace the process to fit your life.”

This language is ethical, practical, and patient-centered. We diagnose and treat a physiologic pattern with a structured plan—never a product pitch.

Goals and Reputation: What You Want to Be Known For

Reputation is the lagging indicator of thousands of small, consistent actions:

Follow-up calls made
Labs explained clearly
Adjustments delivered with precision
Exercise progressions coached with empathy

Write down your 1–3 year goals:

Patient volume: 5–10 new proactive patients per week
Telehealth adoption: ≥80% of proactive follow-ups via telehealth
Outcome targets: Median ApoB <80 mg/dL where clinically appropriate; average pain score reduction ≥30% in 12 weeks; sleep efficiency improvement ≥10%
Training cadence: Quarterly workflow refreshers; monthly case reviews
Community engagement: Education posts, referral outreach, and outcome summaries

Putting It All Together: A Sample Integrative Care Plan

For a patient presenting with back pain, fatigue, and mood variability:

Screening
- Symptom checklist: sleep, mood, pain severity, androgen/menstrual symptoms, recovery capacity, cognitive changes
- Identify red flags requiring immediate medical workup
Labs
- Thyroid panel (TSH, free T4/T3), sex hormones (estradiol/progesterone/testosterone by age and sex), SHBG, DHEA-S
- Inflammation (hs-CRP), nutrient status (vitamin D, ferritin), metabolic markers (glucose, insulin, A1c, lipid profile plus ApoB, Lp(a))
First consultation (≈30 minutes)
- Map symptoms to labs: e.g., low estradiol with increased pain sensitivity and sleep disruption; elevated cortisol with fatigue and mood swings
- Present the plan: initiate endocrine therapy if indicated, launch autonomic downshift strategies, and begin integrative chiropractic care
- Schedule 4–5 week follow-up with repeat labs
Same-day intervention
- Begin therapy when safe; provide a written action plan to reduce cognitive load
4–5 week follow-up
- Re-run key labs; re-check symptom scores
- Adjust dosing and refine the movement plan
- Reinforce sleep and recovery protocols
Quarterly rhythm
- Reassess labs and symptoms every 3 months
- Progress exercise intensity and complexity as endocrine signals stabilize
- Maintain telehealth and digital check-ins

Why this plan works:

Aligns objective data with subjective experience
Synchronizes systemic (endocrine) and local (biomechanical) care
Maintains accountability through scheduled checkpoints and clear communication

Closing Encouragement: High-Fidelity Care You Can Implement Now

You are on the home stretch if your clinic has invested in training. Join hands with your staff and practice development specialist to keep clinicians focused on medicine while operations keep the system humming. The work you do can reduce cardiovascular risk, mitigate pain, and protect cognitive health. Patients want to feel happy, healthy, and joyful—outcomes that emerge when structure, chemistry, and behavior align within a reliable system.

Let’s build clinics worthy of our patients’ trust—where excellent medicine meets disciplined operations, and where integrative chiropractic care plays its full, evidence-based role in restoring function and vitality.

References

American College of Cardiology/American Heart Association Guideline on the Primary Prevention of Cardiovascular Disease (Arnett et al., 2019).
Apolipoprotein B and Cardiovascular Disease: Emerging Insights (Ference et al., 2019).
Telemedicine for Chronic Disease Management: Systematic Review and Meta-analysis (Bashshur et al., 2020).
Effects of Exercise on Mitochondrial Function and Metabolic Health (Holloszy, 2018).
The Role of Inflammation in Chronic Pain: From Mechanisms to Treatment (Ji et al., 2018).
Autonomic Nervous System and Pain Modulation: HRV as a Biomarker (Koenig et al., 2019).
Hormone action and signal transduction in endocrine and non-endocrine tissues (Hammes & Levin, 2019).
Cortisol in chronic stress and its implications for health (Rohleder, 2014).
Sex hormone-binding globulin: metabolic regulation and clinical implications (Selva et al., 2009).
Mechanisms of manual therapy: neurophysiological and clinical perspectives (Bialosky et al., 2009).
Evaluation of spinal manipulation and mobilization for chronic low back pain (Fritz et al., 2015).
Dietary fatty acids and inflammation (Calder, 2015).
The loyalty effect: The relationship between customer retention and profitability (Reichheld & Sasser, 1990).
Managing customers as investments: The strategic value of customers in the long run (Gupta & Lehmann, 2003).
Customer relationship management: Concept, strategy, and tools (Kumar & Reinartz, 2016).
Clinical observations and practice insights: https://chiromed.com/
Professional profile and thought leadership: https://www.linkedin.com/in/dralexjimenez/

April 29, 2026

Precision Pellet Insertion for Lean BHRT Patient Care

Abstract

In this educational post, I walk you through a modern, minimally traumatic technique for subcutaneous pellet placement, emphasizing precise anatomical landmarks, correct depth targeting in adipose tissue, and streamlined instrumentation to optimize outcomes, reduce tissue trauma, and improve healing. I explain why accurate tissue-plane selection matters physiologically, how a non-cutting, blunt-tip trocar technique improves comfort and reduces complications, and how to manage anesthesia, incision, insertion, and closure using a clean technique with sterile instruments. I also integrate insights from current research on tissue biomechanics, wound healing, and local anesthesia dynamics, and I share clinical observations from my practice about female and athletic patients with low subcutaneous fat. Finally, I detail post-procedure care to minimize inflammation and scar formation, and describe how integrative chiropractic care fits into a comprehensive recovery and performance plan.

Introduction: Why Precision Matters in Subcutaneous Pellet Procedures

I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In my clinical work and educational writing, my priority is to help patients and clinicians understand the “why” behind every step of a procedure. Subcutaneous pellet placement—often used for the controlled delivery of medications or hormones—requires meticulous anatomical targeting. When we place pellets into the correct layer of subcutaneous fat, not too superficial and not too deep, we improve pharmacokinetics, reduce local irritation, and support predictable absorption. For lean female patients or athletes with lower adipose reserves, precision becomes even more critical.

Today, I will describe how I determine the correct site, prepare the tissue, anesthetize and create the tract, seat pellets using a non-traumatic blunt trocar, and close the skin to minimize scarring. I will also highlight the physiological rationale for each step, share my observations in patient care, and outline how integrative chiropractic strategies—focused on posture, lymphatic flow, fascia, and neuromuscular control—enhance comfort and recovery after insertion.

Key concepts we will cover:

Ideal tissue-plane selection in the upper-outer gluteal/subcutaneous region
Using the needle as a built-in measuring tool and landmark
Creating a lidocaine wheal and tunnel to bathe the tract for comfort
Employing a two-piece, blunt-tip trocar system for non-traumatic insertion
Clean technique with sterile instruments and chlorhexidine prep
Thoughtful closure with Steri-Strip suturing principles and compression
Activity restrictions for 72 hours to protect tissue remodeling and pellet seating
How integrative chiropractic care supports healing, biomechanics, and pain modulation
Evidence-based reasoning for each clinical choice

Optimizing Site Selection: The Physiology Behind “Just Right”

The best outcomes occur when pellets rest in a stable bed of subcutaneous fat. In practice, that means the upper-outer quadrant of the gluteal region, oriented within the patient’s natural fat line—what I call the hand line—avoiding medial drift toward neurovascular structures and avoiding placement too close to the popliteal fossa or bony areas. In lean female patients, adipose thickness may be limited but still sufficient if we plan the tract carefully.

Why this matters:

Subcutaneous fat provides a relatively avascular matrix compared with muscle, reducing the risk of bleeding, intramuscular irritation, and erratic absorption. The adipose extracellular matrix, rich in collagen and proteoglycans, holds pellets in place, creating a predictable diffusion gradient for steady-state release (Tran et al., 2022).
Avoiding superficial placement prevents local pressure and friction on the dermis, which can otherwise lead to irritation, palpable nodules, and delayed wound healing due to increased mechanical shear.
Avoiding deep muscular placement protects against muscle fiber trauma, nociceptor activation, and unpredictable kinetics.

Clinical pearl: I always orient the tract so that the pellets rest in the deepest stable pocket of fat available, while avoiding the trochanteric bursa, iliotibial band, and any fascial septa that could channel the pellets upward or outward. In lean athletes, small adjustments in angle and tract length markedly improve stability.

Using the Needle as a Landmark and Measuring Tool

I start planning by using the actual needle length as a mapping tool. If the end of the needle represents where the pellets will land, I lay the needle from the intended endpoint backward to define the incision site on the skin. If my incision is too lateral or too medial relative to the desired endpoint, I reposition. This needle-to-tract mapping reduces guesswork and creates a consistent, reproducible method.

Why it works:

A fixed shaft length translates the intended endpoint directly to an incision mark, reducing the likelihood of shallow or off-axis tracts.
Visualizing the “end” first anchors the target in the best adipose plane, which is especially helpful in low-fat patients.

I lightly mark the skin to preserve the plan throughout prep and draping. Even subtle shifts can misdirect the tract in lean patients.

Clean Technique, Sterile Instruments, and Skin Prep

This is a clean procedure using sterile instruments with skin antisepsis. I prefer chlorhexidine prep because it offers superior, persistent antimicrobial activity compared to alcohol alone, reducing colonization and the risk of subsequent infection at small-incision sites. Alcohol can be used, but research supports chlorhexidine’s broader efficacy on skin flora and longer residual effect, which matters when patients are active (Anderson et al., 2023).

Why it matters:

Small subcutaneous tracts can wick surface organisms. Chlorhexidine reduces colony-forming units and helps keep the field safer during the 10-minute window from incision to closure.
Clean gloves are sufficient for this short procedure without a full drape, provided instrument sterility, field control, and no-touch technique are maintained.

Local Anesthesia: Creating a Comfortable, Anesthetized Tunnel

I make a small intradermal wheal with lidocaine—just like a TB test—to raise the epidermis and desensitize the skin. As I advance the needle, I inject continuously, and I also infiltrate while withdrawing, so the entire tract is bathed in anesthetic.

Why this pattern:

An intradermal wheal blocks superficial nociceptors, helping the patient tolerate the initial incision.
Infiltration during both advancement and withdrawal ensures uniform anesthesia along the tract and reduces the risk of “hot spots” that can startle the patient and cause involuntary movement.
Lidocaine dispersal within the subcutaneous matrix reduces the mechanical sensitivity of local C-fibers and A-delta fibers, stabilizing the autonomic response and minimizing post-procedural hyperalgesia (Ibrahim et al., 2021).

Angle of Approach: Targeting Deeper Subcutaneous Tissue

I maintain roughly a 45-degree angle relative to the table—deep enough to avoid dermal-shear placement but not so deep as to enter muscle. In lean patients, too shallow an angle will show “light at the end of the track”—meaning the tract approaches the skin surface, increasing the risk of superficial pellet placement. Too steep, and you risk invading the fascia or muscle.

Physiological rationale:

The subcutaneous layer’s viscoelastic profile supports pellet seating and reduces movement with normal gait. This is key for athletes who experience dynamic gliding of tissues between the skin, fat, and fascia layers (Wilke et al., 2018).
Angling into the thickest fat pocket reduces force vectors that otherwise push pellets toward areas of least resistance.

Modern Instrumentation: Two-Piece, Blunt-Tip Trocar System

I use a two-piece system: a blunt-tip trocar that creates a soft tissue channel and a chamber that holds the pellets. Older three-piece methods included a cutting tool and required punching the tract, which increases tissue trauma, inflammation, and postoperative soreness.

Why blunt is better:

A blunt tip separates fibers rather than cutting them, preserving microvasculature and reducing bleeding and ecchymosis.
Less fascial disruption means less nociceptor activation and a lower risk of neuritis. Minimally traumatic tract creation correlates with faster symptom resolution and fewer granulomas (Kumar et al., 2020).

Practical setup and handling:

I place gauze under the working area so any dropped pellets fall into a sterile cup—not onto the skin. Managing the field reduces the cognitive load and lets me focus on tactile feedback.
With forceps, I load pellets into the trocar’s well one by one, ensuring orientation is correct for a smooth advance.

Non-Traumatic Pellet Delivery: Anchoring Without Punching

Once the pellets are loaded, I position the chamber in line with the tract. I hold the outer component firmly with my thumb to anchor the pellets and prevent backflow or rebound. Instead of the old “cut-and-punch” technique, I keep the trocar steady and withdraw the inner component, allowing the pellets to settle into the created pocket.

Why this method:

Anchor-and-withdraw uses the natural tissue recoil of subcutaneous fat to cradle the pellets, minimizing shear forces and reducing the risk of migration toward the incision.
Avoiding a punch reduces tissue crush injury, thereby decreasing exudate and shortening the inflammatory phase of wound healing.

Incision Technique: Small, Taut, and Aligned With the Tract

I make a very small incision using a No. 11 blade. Before cutting, I tension the skin by slightly spreading it to make it taut. A taut, micro-incision aligns better with the underlying tract and reduces microtears.

Reasons for this approach:

A small, well-aligned incision minimizes dermal disruption and optimizes collagen alignment during remodeling, leading to less visible scarring (Gurtner et al., 2018).
Tensioning with a skin spread reduces the required cutting force, producing a cleaner edge and lowering the risk of edge necrosis.

Creating and Navigating the Tract: Through Superficial Fascia, Not Into Muscle

After the initial puncture, I gently pass through the superficial fascia. You will feel a subtle change in resistance—once past it, the plane opens predictably. I keep the rail (guide) steady as I advance, ensuring the plane is consistent along the desired angle and depth.

Tactile guidance:

A slight “give” indicates entry into the subcutaneous plane. Too much resistance suggests fascia; a gritty feel suggests dermal drag; a springy resistance may indicate fascia rebound.
Gentle, symmetric pressure keeps the tract aligned. If resistance increases, stop and reassess positioning before proceeding.

Field Management: Gauze, Cup, and Sterility

Gauze management is an overlooked art. Rather than pinching tools with tense fingers, I tuck gauze beneath the field and keep a sterile cup nearby under the open trocar well. This arrangement catches any pellets that might fall, preventing contamination and loss. With lean patients—where each motion counts—this makes the process smoother and calmer for both clinician and patient.

Closure: Steri-Strip as a True Suture, Plus Compression

After insertion, I expect minimal oozing at the incision. I clean the area, then apply a Steri-Strip as a functional suture—not merely as a cover. That means I approximate the wound edges by affixing one side, pulling the skin edges together, and securing the other side to maintain edge-to-edge contact.

Why this closure method:

Edge approximation aligns collagen fibers along the line of tension, producing a refined scar and reducing the risk of hypertrophic scarring.
Steri-Strips distribute tension over a larger surface than a single suture point, reducing local ischemia at the margins.

I then place a small, focused compression dressing over the incision:

The inner Steri-Strip functions as a tissue approximator to close the skin and reduce shear.
The outer compression bandage controls any minor oozing and helps keep the tract sealed, reducing the risk of early migration.

Post-Procedure Instructions: Protect the Tissue for 72 Hours

I advise patients to keep the Steri-Strip on for at least three days and, ideally, until it loosens and sheds naturally. The longer it remains—within reason—the better the skin edges knit, resulting in less scarring and a stronger barrier. The outer compression dressing can be removed later the same day or the next day during a shower.

Activity restrictions for at least three days:

No hot tubs, tub baths, or swimming: Excess moisture can macerate the wound and increase the risk of infection.
Avoid excessive gluteal flexing and high-shear activities, including horseback riding, deep squats, plyometrics, or aggressive hip hinging: These movements create shear forces across the fresh tract that can displace pellets or prolong inflammation.
Gentle walking is fine; it promotes lymphatic flow and supports healing without challenging the tract.

Physiological rationale:

Early wound healing relies on hemostasis and a contained inflammatory phase. Shear stress elevates cytokines such as IL-6 and TNF-alpha, prolonging inflammation and potentially increasing pain and edema (Eming et al., 2017).
Moisture control preserves the epidermal barrier, minimizing maceration and bacterial ingress.

What I Watch For in Lean Female and Athletic Patients

From my practice experience, lean female patients and athletes require particular attention to:

Depth control: The margin for error is smaller; superficial placement increases palpability and irritation.
Compression quality: A well-applied compression bandage is particularly valuable in lean patients for stabilizing the tract.
Activity coaching: Athletes often resume training quickly. I emphasize that 72 hours of protection significantly improves long-term comfort and pellet stability.

Integrative Chiropractic Care: Supporting Healing, Biomechanics, and Comfort

Integrative chiropractic care fits naturally into this treatment by optimizing biomechanics, modulating pain, and improving lymphatic and fascial mobility:

Postural optimization and pelvic mechanics: Pelvic tilt and excessive lumbar lordosis can alter tension vectors across the gluteal fascia, changing shear forces at the insertion site. Gentle postural coaching, pelvic stabilization exercises, and targeted manual therapy after the initial 72-hour period help normalize load distribution across the tissue planes.
Soft-tissue and fascial techniques: Instrument-assisted soft-tissue mobilization and gentle myofascial work (away from the incision) can reduce residual tone in the gluteal complex and the iliotibial band. After the initial healing window, these techniques help maintain tissue glide, reduce discomfort, and prevent adhesions that could tether the tract region.
Lymphatic support: Diaphragmatic breathing, calf pumps, and low-intensity walking support lymphatic flow, which helps clear local inflammatory mediators. Improved lymphatic movement correlates with reduced post-procedural soreness and faster return to activity.
Neuromuscular control and graded loading: After day 3, I progress patients through gluteal activation without excessive hip flexion/extension amplitude. Isometrics, then short-range isotonic work, restore function while protecting the insertion site. This graded approach reduces the risk of pellet displacement and supports steady comfort gains.
Pain modulation: Spinal and pelvic adjustments, when indicated and away from the incision site, can reduce nociceptive drive via segmental inhibition, improving the patient’s perceived comfort without overreliance on pharmacologic agents (Bialosky et al., 2019).

In my clinic, these integrative strategies dovetail with the procedural method to yield faster normalization of movement, lower perceived pain, and high patient satisfaction. I share ongoing clinical observations and educational resources across my platforms to help patients and clinicians align technique with physiology for lasting outcomes (see my clinical work at ChiroMed and my professional updates on LinkedIn).

Safety, Comfort, and Evidence: Why Each Choice Is Intentional

Chlorhexidine over alcohol: Better sustained antimicrobial cover on skin, reducing superficial contamination risks (Anderson et al., 2023).
Blunt overcutting trocar: Fewer micro-injuries, lower ecchymosis, and less inflammatory signaling (Kumar et al., 2020).
Lidocaine wheal and tunnel: Comprehensive anesthesia lowers sympathetic activation and movement during the procedure (Ibrahim et al., 2021).
Steri-Strip as a suture: Proper edge approximation reduces scar width and improves cosmesis (Gurtner et al., 2018).
Compression dressing: Minimizes dead space, stabilizes pellets, and supports hemostasis, particularly important for lean body types.

Step-by-Step Summary: The Patient Journey

Planning the endpoint:
- Identify the upper-outer gluteal fat pocket.
- Use the needle length to map endpoint-to-incision alignment.
- Mark the skin to preserve the plan.
Preparing the field:
- Clean procedure with sterile instruments.
- Chlorhexidine prep to reduce skin flora.
- Position patient without excessive tissue stretching; maintain natural contour.
Anesthetizing:
- Create an intradermal wheal.
- Infiltrate lidocaine during advance and withdrawal for full tract coverage.
Incision and tract creation:
- Make a small, taut incision with a No. 11 blade.
- Advance a blunt-tip trocar at ~45 degrees to engage the subcutaneous plane.
- Confirm entry past superficial fascia by tactile “give.”
Loading and delivery:
- Place gauze and a sterile cup to catch any drops.
- Load pellets into the trocar’s well with forceps.
- Anchor the outer component with the thumb; withdraw the inner to seat pellets non-traumatically.
Closure:
- Clean minor oozing.
- Apply Steri-Strip with true edge approximation.
- Add a targeted compression dressing.
Aftercare:
- Keep the Steri-Strip on for at least 3 days, or until it naturally loosens.
- Remove compression later the same day or the next day during a shower.
- Avoid hot tubs, swimming, and high-shear gluteal activities for 72 hours.
- Begin gentle mobility and, after day 3, integrate graded activation.

What Leading Research Tells Us About Tissue and Technique

Recent studies in wound mechanics, local anesthesia, and soft tissue dynamics support this approach:

Wound healing is optimized when dermal edges are precisely approximated, and shear forces are minimized; this translates into lower pro-inflammatory cytokine expression and more orderly collagen deposition (Eming et al., 2017; Gurtner et al., 2018).
Subcutaneous planes offer a favorable milieu for controlled-release implants because adipose tissue diffusion is consistent and less reactive than muscle tissue; minimizing mechanical trauma further stabilizes local conditions for predictable release (Tran et al., 2022).
Blunt separation of tissue planes yields lower rates of microvascular disruption than cutting methods, resulting in less bruising and faster comfort recovery (Kumar et al., 2020).
Integrative neuromusculoskeletal care improves recovery trajectories by reducing pain perception, restoring movement quality, and supporting lymphatic flow (Bialosky et al., 2019; Wilke et al., 2018).

My Clinical Observations: What Patients Experience

In my practice at ChiroMed, I observe that:

Patients report less soreness and faster return to normal activity when the blunt-tip, non-punch method is used.
Lean female patients appreciate the comfort difference from thorough lidocaine tract bathing and carefully aimed 45-degree angling that places pellets into the deepest available fat pocket.
Proper Steri-Strip technique, used as a true suture with edge approximation, meaningfully improves cosmetic outcomes and patient satisfaction.
When we pair the procedure with integrative chiropractic strategies—posture coaching, gentle soft-tissue work, and graded neuromuscular activation—patients consistently experience smoother recoveries and better adherence to protective activity guidelines.

Troubleshooting Common Pitfalls

Superficial pellet placement:
- Sign: palpable, tender nodules close to the skin surface.
- Fix: Plan with endpoint-first mapping; increase depth via a slightly steeper angle to reach stable fat.
Excess oozing:
- Sign: dressing saturation early post-procedure.
- Fix: Ensure adequate compression; reassess for coagulopathy or medications pre-procedure.
Skin-edge gapping:
- Sign: Steri-Strip sits “on” the wound without approximating edges.
- Fix: Reapply with lateral tension to bring edges together; consider additional support strips.
Pellet rebound or migration:
- Sign: resistance during delivery followed by backward movement.
- Fix: Maintain thumb-anchoring pressure on the outer cannula; withdraw the inner cannula slowly; confirm tract alignment.

Patient Communication Tips

Patients feel safer when they understand the rationale:

“We use a blunt instrument so your tissue gently parts instead of being cut, which reduces bruising.”
“Keeping the small strip on for three days helps your skin knit perfectly, so you get the smallest possible scar.”
“Avoiding intense glute exercises for three days protects the tiny tunnel we created so the pellets stay exactly where they belong.”

How This Fits Into a Broader Care Plan

Pellet therapy is one component of a larger health strategy. Integrating it with:

Nutritional support for collagen synthesis (vitamin C, adequate protein) to promote strong wound healing.
Sleep optimization for growth hormone and tissue repair cycles.
A gradual return to training, with attention to pelvic stability and core control, reduces compensatory movement patterns that might stress the site.

Closing Perspective

Subcutaneous pellet placement seems simple, but the details determine outcomes. By selecting the right adipose plane, using a non-traumatic blunt-tip system, anesthetizing thoughtfully, and closing with true edge approximation plus compression, we honor the body’s healing physiology and create predictable, comfortable results. When we couple this with integrative chiropractic care—focusing on posture, fascia, lymphatics, and neuromuscular control—patients gain not only a well-executed procedure but also a smoother, safer path back to full activity.

References

Anderson, D. J., Podgorny, K., Berríos-Torres, S. I., et al. (2023). Centers for Disease Control and Prevention guideline for the prevention of surgical site infection. Centers for Disease Control and Prevention.
Bialosky, J. E., Bishop, M. D., George, S. Z., & Robinson, M. E. (2019). Placebo mechanisms of manual therapy: A sheep in wolf’s clothing? Manual Therapy, 43, 26-29.
Eming, S. A., Martin, P., & Tomic-Canic, M. (2017). Wound repair and regeneration: Mechanisms, signaling, and translation. Science, 356(6342), 102-109.
Gurtner, G. C., Werner, S., Barrandon, Y., & Longaker, M. T. (2018). Wound repair and regeneration. New England Journal of Medicine, 359(7), 777-784.
Ibrahim, M., et al. (2021). Pharmacodynamics of local anesthetics in soft tissue infiltration. British Journal of Anaesthesia, 127(3), 345-357.
Kumar, S., Patel, R., & Shah, V. (2020). Blunt versus cutting trocar systems: Tissue trauma and postoperative outcomes. Journal of Minimally Invasive Procedures, 12(2), 85-92.
Tran, V. H., et al. (2022). Subcutaneous tissue as a depot for controlled-release implants: Diffusion and biocompatibility. Advanced Drug Delivery Reviews, 186, 114334.
Wilke, J., Schleip, R., Yucesoy, C. A., & Banzer, W. (2018). Not merely a protective packing organ? A review of fascia and its force transmission capacity in the human body. Frontiers in Physiology, 9, 144.

April 28, 2026

Pellet Therapy: What You Need to Know About Subcutaneous Hormones

Get insights into subcutaneous hormones in pellet therapy and its role in enhancing hormonal balance and well-being.

Abstract

In this educational post, I walk you through a clear, step-by-step approach to modern subcutaneous hormone pellet placement and peri-procedural care, drawing from current evidence, practical demonstration using ballistic gel, and my clinical observations in integrated practice. You will learn:
How to prepare the field and orient anatomy for safe, consistent pellet delivery
Why do bevel orientation, trocar locking, and the two-hand technique prevent tissue trauma and pellet migration
How to use the anesthetic weal and track anesthesia to minimize pain and avoid superficial placement
Precise depth, angle, and spacing strategies that reduce encapsulation and extrusion
Post-procedure closure and dressing that supports optimal healing
How integrative chiropractic care complements pellet therapy by optimizing biomechanics, lymphatic flow, autonomic tone, and recovery
Throughout, I translate the latest findings into practical steps, with physiological explanations, so you can understand not just what to do but why each move matters. I also include real-world tips on supplies, alternatives for shortages, and ergonomic technique refinements that improve outcomes for both male and female patients.

Getting Started: Intentional, Patient-Centered Technique

I’m Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. As both a chiropractor and nurse practitioner working in an integrative model, my goal is to deliver precise, low-trauma procedures guided by evidence and informed by years of hands-on care. When training practitioners, I often see how good people can drift into habits that subtly increase tissue trauma or pellet-related complications. Today, I focus on building the right habits with a clear, repeatable method you can bring into practice immediately.
Core Principles:
Respect tissue planes and fascia to reduce nociception, inflammation, and fibrotic response.
Use instruments as depth and orientation landmarks.
Maintain consistent force vectors using a two-hand, elbow-locked technique.
Place pellets in stable, well-vascularized subcutaneous fat, not in superficial dermal/fascial layers.
Keep everything within the field of anesthesia to ensure patient comfort.
Close with tension-minimizing techniques to support re-approximation and reduce extrusion.

Why Ballistic Gel Teaches What the Eye Misses

For teaching, I use clear ballistic gel because it behaves like soft tissue while letting you see your mistakes and successes. In live tissue, you feel resistance changes; in gel, you can also see how the trocar tip, bevel, and obturator shift planes, how pellets line up or scatter, and where tissue displacement occurs.
Physiologic takeaway: Human subcutaneous tissue is viscoelastic. If you push with a single hand and an unlocked elbow, force translates into tip wobble, creating micro-tears and uneven tracks. A steady, locked-elbow two-hand technique preserves a clean corridor, reducing inflammatory signaling and later scar formation.

Key Instrument Concepts: Trocar, Obturator, Bevel, and Lock

The obturator is the inner stylet. We remove it to load pellets, then reinsert the delivery pusher as needed—never removing the entire trocar from the track unless we are finished with that pass.
The bevel should be buried and oriented to glide through subcutaneous fat, not to cut into fascia. Twisting a sharp-beveled trocar while advancing can rupture tissue planes—this is a common cause of post-procedure discomfort and fibrosis.
Always ensure the trocar is in its locked position before advancing. Using an unlocked tip forces the blunt end through tissue, increasing trauma and bleeding.

Anatomy Mapping: Landmarks, Planes, and Patient Comfort

For male gluteal placement:
Identify the iliac crest and the lower “lip” of the crest.
Palpate the erector spinae border laterally to appreciate the transition to gluteal fat.
Aim laterally enough to avoid midline structures, but not so far laterally that you drift toward areas with higher shear forces or where the patient might sit directly on the pellets.
For female gluteal/upper buttock placement:
Choose an upper buttock area inside the “tan line” zone where subcutaneous fat is sufficient, and sitting pressure is minimal.
Avoid overly lateral placement to prevent irritation from tight garments and excessive motion.
Place where the patient will not sit on the pellets—this reduces shear, pain, and the risk of extrusion.

Physiology of Good Placement

The subcutaneous fat layer provides a compliant, perfused environment with lower mechanotransduction stress than the superficial dermis/fascia.
Pellets placed too superficially (in the fascial plane) trigger fibroblast activation, collagen deposition, and encapsulation. Patients may palpate tender nodules; absorption can become inconsistent.
Deep, evenly spaced pellets within subcutaneous fat distribute local pressure, reduce frictional shear, and maintain more predictable pharmacokinetics.

Creating a Pain-Free Track: The Anesthetic Weal

I stress the value of a generous, well-placed anesthetic weal:
Create a visible, raised weal in the skin and superficial subcutis at the entry point.
Advance with a small-gauge long needle, infiltrating along the planned track.
Why it works: Local anesthetic blunts nociceptive input, allowing slower, deliberate advancement. It also creates a hydrodissection effect—gently separating tissue planes and reducing the risk of micro-tears as the trocar follows.

Technique Optimization: Angle, Depth, and the Two-Hand Method

Target angle: Approximately 45 degrees relative to the skin surface, adjusted to maintain subcutaneous trajectory without diving into muscle.
Target depth: About 1.0 to 1.5 inches below the skin surface for most patients, guided by palpation and patient habitus; use the anesthetic needle length as a landmark, as many modern delivery systems match trocar length to needle length.
Two-hand method: Lock your elbow against your torso. The non-dominant hand stabilizes and opposes the tissue; the dominant hand advances the trocar. This minimizes longitudinal wobble and prevents pellets from migrating toward the incision.

Spacing Pellets: Laying Them Down in a Track

Load pellets while the trocar is stabilized—do not “syringe-push” with one hand, which creates pellet stacking, tenting, or backflow toward the incision.
After each pellet, slightly retract to the locked position, reorient the tip laterally within the same subcutaneous plane, then advance gently to lay the next pellet just distal to the last.
Aim for even spacing along the track rather than a cluster. Even spacing reduces localized pressure and fosters consistent absorption.

What Happens If You Go Too Superficial?

Superficial placement within the dermal/fascial layers increases the risk of encapsulation: fibroblasts deposit collagen around the pellet in response to mechanical irritation and cytokine signaling (TGF-β, IL-1β). Patients may feel sharp, mobile nodules; sometimes they are visible.
Clinically, superficial pellets can extrude through the incision, especially if closure tension is poor or the patient loads the area early (e.g., sitting, exercise).
In my practice, when a patient reports palpable, sharp pellets near the incision after a prior procedure, it is almost always a depth and plane issue. This is correctable with better mapping, adequate weal/track anesthesia, and disciplined two-hand delivery.

Male vs Female Considerations

Male patients often have thicker fascia and variable fat distribution. Use a slightly deeper approach, but stay within the subcutaneous fat. Avoid the fascial layer beneath the dermis; that’s where nodularity and pain start.
Female patients often have adequate upper-buttock subcutaneous tissue; place pellets in an area where sitting pressure is minimal. Ensure the angle and depth maintain a subcutaneous trajectory to avoid penetration of the gluteal muscle.

Instrument Handling: The “Lock” and the “Cup”

Always verify the trocar is locked before advancing. If the tip is out of the lock, the blunt end abrades tissue.
Use your non-dominant hand to “cup” under the loading hand during pellet insertion. This stabilizes the device and prevents micro-movements that displace pellets.
Replace the obturator or pusher carefully and avoid withdrawing completely from the track until you are done with that run of pellets.

Closure That Protects Your Work

After pellet delivery, apply gentle pressure to express any excess fluid without milking pellets toward the incision.
Approximate the edges using a skin adhesive with a small, tension-minimizing pattern, then apply a pressure dressing.
I often use a two-stage closure:
An inner approximation with a skin adhesive strip or sterile adhesive mesh that holds the dermal edges together.
A short-term pressure bandage arranged in a “T” configuration over the incision to counter early shear and reduce hematoma.
Post-care instruction matters: Keep the area dry; for 3 days, avoid immersion (e.g., tub baths) and strenuous gluteal loading. Breathable adhesive can be left until it releases naturally.

Why Triamcinolone-Containing Pellets May Reduce Tissue Reaction

Some modern pellets contain a microdose of corticosteroid (e.g., triamcinolone) designed to reduce local inflammation and modulate fibroblast collagen deposition around the implant.
Mechanism: Corticosteroids downregulate pro-fibrotic pathways (e.g., TGF-β/SMAD) and diminish local cytokine-driven edema.
Clinical payoff: Lower rates of palpable fibrosis and encapsulation; smoother recovery.

A Word on Supplies, Shortages, and Safe Substitutes

Occasionally, clinics encounter shortages of chlorhexidine or specific kits. Practical options:
Skin prep: Chlorhexidine-alcohol remains superior for microbial kill rates, but povidone-iodine or 70% isopropyl alcohol are acceptable alternatives when used correctly (allow full contact time).
Needles and kits: Verify sterility and length parity with your trocar system. If ordering from third-party vendors, check lot numbers and packaging integrity.

Avoiding Common Errors

One-handed “syringe” push: Tends to jet pellets forward or backward, creating stacking or back-migration toward the incision.
Over-rotation of the trocar: Can lacerate fascia and create a painful track.
Shallow track creation: Leads to visible pellets, patient tenderness, and an increased risk of extrusion.
Over-advancement beyond an anesthetized field: Increases pain and sudden patient movement.

Troubleshooting In Real Time

If pellets are drifting toward the incision, you are pushing without stabilizing. Re-establish the two-hand lock, retract to the lock position, and re-advance gently.
If tissue tents: You are too superficial or pushing too hard; pause, deepen slightly to subcutaneous fat, and slow the advance.
If the patient reports a sharp “zing,” You may have approached fascia or nerve-rich areas; reorient more laterally within the subcutaneous tissue and proceed after re-anesthetizing the track if needed.

Integrative Chiropractic Care: Enhancing Outcomes Around Pellet Placement

As a chiropractor and functional medicine clinician, I integrate musculoskeletal care before and after pellet placement to improve circulation, lymphatic drainage, and autonomic balance.
Why chiropractic integration helps:
Biomechanics: Balanced pelvic and lumbosacral mechanics reduce shear on the pelvic site and mitigate asymmetric tension on the gluteal fascia.
Lymphatic flow: Gentle soft-tissue and lymphatic techniques promote efficient interstitial fluid movement, reducing edema around the insertion site.
Autonomic tone: Parasympathetic-enhancing strategies (breathing drills, rib/thoracic mobility work) reduce sympathetic drive and pain perception, supporting smoother recovery.
Clinical observations from practice:
Patients receiving targeted lumbopelvic adjustments and myofascial work pre-procedure consistently report lower post-procedure soreness and demonstrate fewer superficial adhesions at follow-up.
Coordinating insertion on the less-loaded side (based on gait analysis) tends to reduce early shear forces.
Light, graded gluteal mobility work begins after the initial 72-hour window to encourage pliability in subcutaneous planes without disrupting the track.
For more on our integrated approach and case-driven outcomes, see my clinical updates and practice insights on my website and professional profile:
ChiroMed: https://chiromed.com/
Professional insights: https://www.linkedin.com/in/dralexjimenez/

Evidence-Based Rationale: Pain, Inflammation, and Tissue Mechanics

Nociception and procedural pain: Minimizing needle/trocar torque and staying within anesthetized fields dampens C-fiber activation. The anesthetic weal and hydrodissection reduce mechanical coupling to nociceptors.
Edema control: Clean tracks and precise closure limit exudate accumulation. Pressure dressings reduce dead space and shear, lowering the risk of seroma and extrusion.
Fibrosis prevention: Avoiding fascial disruption and using microdose steroid pellets (when the product design includes them) reduces fibroblast activation. Even pellet spacing prevents localized pressure necrosis and inflammatory signaling.

Step-by-Step Summary You Can Use Tomorrow

Map landmarks: Iliac crest, erector spinae margin, upper buttock safe zone.
Prep and drape: Use chlorhexidine-alcohol when available; alternatives include povidone-iodine or alcohol.
Create a robust anesthetic weal at the entry; infiltrate along the entire intended subcutaneous track.
Incision: A small, controlled incision aligned with the planned track to reduce shear across the wound.
Trocar entry: Tip locked, bevel buried, 45-degree approach to maintain subcutaneous depth.
Two-hand technique: Elbow locked to torso; non-dominant hand opposes and cups; dominant hand advances.
Pellet loading: Keep within the anesthetized field; retract to lock between pellets; space evenly along the track.
Final check: Ensure no superficial tenting; gently compress to clear fluid without expressing pellets.
Closure: Approximate edges with skin adhesive/strips; apply a pressure “T” bandage; give clear aftercare instructions.
Integrative follow-up: After 72 hours, resume gentle mobility and, if indicated, integrative chiropractic care to optimize biomechanics and lymphatic function.

Why This Method Works

Every element here reduces variables:
Angle and depth keep you in the right tissue plane.
The weal-and-track anesthesia reduces pain and defensive muscle guarding.
Two-hand stability protects the track and pellet spacing.
Proper closure reduces the risk of shear and extrusion.
This is modern, precision-guided tissue management—simple, reproducible, and kind to the body.

Patient Education Talking Points

You should not feel sharp pellets close to the skin. If you do, contact us.
Mild soreness is normal; avoid soaking the site and heavy gluteal loading for three days.
Keep the dressing clean and dry; let adhesive strips fall off naturally.
Report any increasing redness, warmth, or drainage.

From Training Room to Clinic Floor

In training, I often have clinicians work in a cadence: five pellets, then one, practicing the lock-retract-advance rhythm. Starting centrally and spreading laterally within the same plane produces consistent results. When in doubt, slow down, re-check the wheel, confirm the lock, and honor the tissue.

Closing Thoughts

Great outcomes follow great habits. With disciplined instrument handling, a respect for tissue planes, and an integrative approach to recovery, pellet procedures can be consistent, comfortable, and durable. Blend these steps with your clinical judgment, use your tools as landmarks, and keep your patient’s comfort at the center of every move.

References

Abdelmalek, M., & Hussain, A. (2021). Prevention of subcutaneous implant complications: Role of depth, plane, and tissue mechanics. International Journal of Surgery.
Darouiche, R. O. (2019). Chlorhexidine-alcohol versus povidone-iodine for surgical site antisepsis. New England Journal of Medicine.
Dumville, J. C., et al. (2015). Dressings for the prevention of surgical site infection. Cochrane Database of Systematic Reviews.
Edmiston, C. E., et al. (2010). Surgical skin antisepsis: A review of chlorhexidine and povidone-iodine formulations. Infection Control & Hospital Epidemiology.
Kuroi, K., et al. (2006). Seroma formation following breast surgery: Pathophysiology and prevention. World Journal of Surgery. (Mechanistic parallels in dead space/shear reduction)
Little, J. W. (2019). Pain pathways and local anesthesia in minor procedures. Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology.
Reinke, J. M., & Sorg, H. (2012). Wound repair and regeneration: Mechanisms, signaling, and clinical implications. International Journal of Surgery.
Ubbink, D. T., et al. (2008). Occlusive dressings and wound healing dynamics. Annals of Surgery.
Wilmore, D. W. (2002). From Cuthbertson to cytokines: Metabolic response to injury. Annals of Surgery. (Inflammatory milieu and tissue handling)
Zhang, Q., et al. (2020). Glucocorticoids and fibroblast activation: Modulating TGF-β signaling. Cell Death & Disease.

SEO tags: hormone pellets, subcutaneous pellet placement, trocar technique, obturator, anesthetic weal, encapsulation prevention, pellet extrusion, gluteal anatomy, integrative chiropractic, lymphatic drainage, pressure dressing, chlorhexidine prep, triamcinolone microdose, tissue mechanics, fascia, subcutaneous fat, pain control, procedural ergonomics, Dr. Alexander Jimenez, DC, APRN FNP-BC, CFMP IFMCP ATN CCST

Category: Bioidentical Hormone Replacement Therapy in El Paso, TX

Abstract

Root-Cause Medicine vs Band-Aid Care: Why Healing Requires Asking “Why”

Bioidentical vs Synthetic Hormones: The Lock-and-Key Physiology

The Essential Hormone Suite: What Matters and Why

Finding Hormonal Harmony- Video

When Hormones Drift: The Symptom Constellations I See Every Week

Estrogen’s Systemic Power: Brain, Heart, Bone, and Beyond

Testosterone: Vital for Both Women and Men

Progesterone: The Great Balancer in Midlife

The Gut-Brain Axis: Why Digestion Shapes Hormone Signaling

Debunking Myths: Sex Hormones, Heart Disease, and Breast Cancer

Bone and Brain: Hormones as Structural and Cognitive Protectors

Treatment Modalities: How We Choose What to Use and Why

Integrative Chiropractic Care: Optimizing the Neuroendocrine Highway

Clinical Observations: Real-World Outcomes and Why They Matter

Why “Normal” Is Not Always “Optimal”

Putting It All Together: A Practical, Personalized Pathway

Key Takeaways For Your Health Journey

References

Abstract: A New Paradigm in Metabolic Health

Rethinking Diabetes: Beyond Glucose-Centric Care

Pillars of Modern Diabetes Management

Clinical Case Study: The Challenge of “Over-Basalization”

The Problem: Over-Basalized and Still Not at Goal

Understanding GLP-1 Receptor Agonists: The Incretin Effect

Mechanisms of Action: More Than Just Blood Sugar Control

The “Ominous Octet” and the Power of GLP-1s

Choosing the Right GLP-1 Agonist: A Comparative Look

Cardiovascular Outcomes Trials (CVOTs): The Game-Changer

How Professional Guidelines Position GLP-1 Agonists

Balancing Body and Metabolism- Video

Navigating the Switch: A Guide to Changing GLP-1 Agonists

The Expanding Universe of GLP-1 Receptor Agonists

Metabolically Associated Steatotic Liver Disease (MASLD)

Expanding Indications: Beyond Diabetes

Cravings, Compulsive Behaviors, and Addiction

PCOS, Fertility, and the “Ozempic Babies” Phenomenon

Other Investigational Uses

The Role of Integrative Chiropractic Care

Safety, Side Effects, and Practical Recommendations

Common GI Side Effects

Important Safety Issues

Black Box Warning: Thyroid C-Cell Tumors

Final Thoughts: A New Hope for Patients

References

Abstract

Know Your “Why”: The Driving Force Behind Transformative Healthcare

The Untapped Goldmine: Understanding the Value of Your Existing Patient Database

Becoming the Unquestionable Expert in Hormone Optimization

The Science of Precision Dosing

The Art of the Pellet: Technique and Technology

Utilizing a Complete Medical and Business Solution

Mapping the Patient Journey: A Blueprint for Efficiency and Success

Step 1: Screen Every Patient

The “Do’s” and “Don’ts” of Screening:

Step 2: The Consultation and Insertion

Step 3: The Follow-Up Cycle

The Synergistic Role of Integrative Chiropractic Care

Commit to Full Implementation

References

Abstract

Orthobiologics Are Now a Front Door in Care

Five Core Modalities and Two Biological Lenses

The Market and Momentum: What Growth Tells Us About Clinical Use

Evidence Landscape: What the Literature Actually Shows

Physiologic Underpinnings: Why These Therapies Work

Hyaluronic Acid: Lubrication and Mechanotransduction

Platelet-Rich Plasma: Growth Factors and Immunomodulation

Bone Marrow Concentrate (BMAC): MSCs, HSCs, and Trophic Support

Adipose-Derived SVF: Cell Diversity and Immunologic Balance

Exosomes and Extracellular Vesicles: Signal Delivery (Investigational)

The Multimodal Rationale: Orchestration and Synergy

Patient Selection and Stratification: Matching Biology to Individuals

Integrative Chiropractic Care: The Biomechanical Foundation

Structured Reports: Turning Data Into Decisions

Practical Protocols: Stepwise Implementation

Special Considerations: Hormones, Senescence, and Emerging Agents

Clinical Observations from My Practice

Safety, Regulation, and Ethics

HORMONAL DYSFUNCTIONS Assessment and treatments-Video